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Abstract 
Aptamers are single stranded DNA or RNA molecules that can bind targets with high 
affinity and specificity. They are selected in vitro from a large library of synthetic oligos via 
Systematic Evolution of Ligand by Exponential enrichment (SELEX) process. Conventional 
SELEX techniques using affinity chromatography and nitrocellulose filtration have identified 
aptamers for a wide range of targets. Although proven successful, the conventional SELEX is 
also time-consuming and labor-intensive. Capillary electrophoresis-SELEX (CE-SELEX) has 
later been introduced for aptamer selection, which greatly reduces the selection time and the 
number of cycles needed and minimizes the non-specific interactions and steric hindrance. 
CE-SELEX has been previously performed mainly against large protein targets. A small 
molecule target N-methyl mesoporphyrin (NMM) is now proved to be suitable for CE-SELEX. 
Aptamers with high nM to low µM affinity are selected by CE-SELEX and two out eight 
randomly picked sequences are also capable of catalyzing the corresponding metal insertion 
reaction. It greatly expands the capability of CE-SELEX and indicates that any target that can 
generate enough change in hydrodynamic size of the oligos upon binding can be used in CE-
SELEX. Not only have we explored the low size limitation of targets for CE-SELEX, but also we 
have applied CE-SELEX against a fully intact membrane target - transferrin receptor (TfR) which 
is difficult for conventional SELEX. Aptamers with a few tens of nM Kd have been selected after 
four rounds of CE-SELEX. These aptamers binding receptors involved in receptor-mediated 
endocytosis process could be potentially engineered for transporting therapeutic cargos for 
treating intracellular targets. 
Besides aptamer selection using CE-SELEX, binding interactions between DNA/RNA 
analogs and important cardiac muscle proteins have also been studied. Using affinity CE and 
fluorescence polarization measurements, various DNA/RNA analogs, such as oligos of different 
lengths, L-DNA, O-methyl RNA, and Ca2+ pump Sarco(endo)plasmic reticulum Ca2+-ATPase 
(SERCA) and regulatory protein phospholamban (PLN), and contractile proteins such as troponin 
and myosin have been employed in the study. This sequence-independent binding affinity 
indicates possible direct nucleic acid regulation effect on protein functions and shows their 
potential as drug candidates for PLN super-inhibition caused heart failure. 
Finally, other than binding affinities, catalytic activities of nucleic acid oligos have also 
been assessed. A novel platform allowing multiple turnover reactions of catalytic sequences has 
been designed and fabricated in PDMS. Single enzyme molecules have been detected 
successfully and their kinetics have been studied using the microwell array device as a proof-of-
concept. Unfortunately, when applying DNA/RNA libraries, we can’t detect any catalytic 
sequences, indicating either the abundance or catalytic activity is too low to be detected. 
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1.1 Functional Nucleic Acids 
All life in today’s world is almost exclusively based on the nucleic acids genomes and 
protein based enzymes. It has been traditionally believed that the chemical uniformity of nucleic 
acids would make them function only for genetic information storage and transfer. However, in 
vitro selection has discovered a number of nucleic acid sequences for binding and catalysis 1, 
which demonstrates the great structural and functional versatility of nucleic acids. Although a 
nucleic acid molecule is comprised of only four chemically similar subunits, RNA and single 
stranded DNA (ssDNA) can fold into various complex secondary and tertiary structures (Figure 
1.1) and form binding sites and catalytic centers much like proteins. RNA and ssDNA capable of 
binding targets are named aptamers meaning fit. Sequences that are able to catalyze reactions are 
named ribozymes for catalytic RNA or deoxyribozymes for catalytic DNA. 
 
Figure 1.1. (a) Secondary and (b) tertiary structures of an ATP aptamer 2. (c) Secondary and (d) 
tertiary structures of a Hammerhead ribozyme 3. 
1.1.1 Aptamers 
Aptamers are in vitro selected short single stranded DNA (ssDNA) or RNA molecules 
that can bind certain targets with high affinity and specificity. The in vitro selection process 
requires the sequences to have two constant primer binding regions for polymerase chain reaction 
(PCR) amplification of bound sequences. A central random region of 30-80 bases is also required 
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for various folding of the ssDNA or RNA structures. A ssDNA or RNA library containing a large 
number of random sequences would have a lot of unique folded structures, such as stem, loop, 
bulge, and G-quadraplex structures. Through in vitro selection, sequences with the right folding 
and shape that fit the binding sites of the target can be selected and amplified from the other non-
binding sequences. A number of aptamers have been selected for various target molecules 
including proteins 4-6, peptides 7, 8, small molecules 9, metal ions 10, 11, and even organelles 12 and 
entire cells 13. 
In addition to aptamers with natural RNA or ssDNA sequences, a number of 
modifications have been introduced to enhance the stability and bioavailability of aptamers. RNA 
generally has lower in vivo stability than ssDNA due to the presence of the 2’-OH group on the 
ribose moity. Therefore, it has been substituted by a number of modifications including 2’-fluoro, 
amino and O-methyl groups to increase the biostability 14-16. Both ends (5’ and 3’) of RNA 
aptamers are vulnerable sites for exoribonuclease degradation. Circular RNA aptamers that join 
both ends of the linear form can be used to increase the resistance to nuclease degradation 17. The 
3’ or 5’ capping modification can also improve the stability of aptamers against exonuclease 
degradation 18. Locked nucleic acid (LNA) provides a more rigid structure and the reduced 
conformational flexibility renders a high aptamer stability against degradation 19. Spiegelmers are 
the mirror images (L- form) of natural D-aptamers 20, 21. They are intrinsically resistant to 
enzymatic degradation due to the fact that they are not recognized by natural enzymes built from 
L-amino acids. Spiegelmers are developed through mirror-image SELEX in which natural D-
oligonucleotides are selected against unnatural peptide targets with D-amino acids building 
blocks. Then the corresponding L- form of the selected D-aptamers would bind the natural L-
peptide targets according to the principle of chirality. This technique eliminates the necessity of 
tedious post-SELEX modification for the selected aptamers. Moreover, in order to lower renal 
clearance rate of the relatively small aptamers, polyethylene glycol (PEG) moity has been added 
to aptamers to increase the effective molecular size and prevent them from cleared via kidney too 
fast 22, 23. 
Compared to their protein counterparts - antibodies, aptamers possess many advantages 24. 
Aptamers can be selected in vitro and cost-effectively synthesized once their sequence is 
determined while the generation of antibodies requires animal immunization. They can work 
under non-physiological conditions that may be fatal for antibodies. They can be easily modified 
by a variety of functional groups and attached to solid phase substrates using various chemistries. 
They have long shelf life and can be denatured and renatured easily. They are typically smaller 
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than antibodies. And most importantly, aptamers can be selected for virtually any kind of targets, 
but antibodies can only be raised against targets that generate immune response. 
1.1.2 Catalytic Nucleic Acids 
The first discovery of RNA with enzyme-like properties was in 1982 when a pre-rRNA 
from Tetrahymena was found to undergo autocatalytic rearrangements 25. In later years, a couple 
of natural occurring catalytic RNA molecules have been discovered, such as hammerhead, hairpin, 
hepatitis delta virus (HDV), varkud satellite (VS), group I intron, group Ⅱ  intron and 
ribonuclease P (RNase P) 3. They play important roles in RNA cleavages and ligations. This has 
led people to think of the prebiotic world hypothesis which was brought into notice by Gilbert in 
1986 26. In this hypothesis, it is assumed that unlike the current world which uses proteins for 
enzymatic reactions and nucleic acids for genetic information storage and transfer, there was a 
stage in early life which uses only one molecular species-the nucleic acid that serves to carry both 
genetic information and enzymatic activities. Such a prebiotic stage requires nucleic acids to have 
great diversity and potential in catalyzing chemical reactions. Great efforts have been put into the 
discovery of new nucleic acid catalysts. Using in vitro selection and transition state analog 
methods, people have selected a broad range of artificial ribozymes and also deoxyribozymes 
with various activities, such as RNA/DNA cleavage 27-29 and ligation 30, 31, biphenol isomerization 
32, 33, Diels-Alder reaction 34, 35, porphyrin metalation 36-38, ester hydrolysis 39, aminoacylation 40-42, 
peptide bond formation 43-45, N-glycosidic bond formation 46 and hydrolysis 47, N-alkylation 48, S-
alkylation 49, Michael addition 50, aldol condensation 51 and Claisen condensation 52. This not only 
leads support to the prebiotic world hypothesis, but also indicates the great potential of nucleic 
acids to be used as novel biocatalysts in biotechnology and organic synthesis. 
Ribozymes and deoxyribozymes take a number of approaches to carry out catalysis quite 
resembling protein enzymes. 1) General acid-base catalysis. Deprotonation of 2’ hydroxyl group 
makes RNA a strong nucleophile. The oxyanion in the phosphate can be protonated and become a 
good leaving group. 2) Conformational effects. Just as a protein must fold into its active 
conformation, nucleic acid catalysts must also fold into a proper conformation to orientate the 
substrates and employ proximity effect. 3) Transition state stabilization. They can lower the 
activation energy of a chemical reaction by binding more tightly to the transition state than the 
ground state. 4) Electrostatic effect. Metal ions, nucleobases and phosphate groups apply 
electrostatic effects to assist catalysis. 5) Cofactors. Metal ions and amino acids can be introduced 
as cofactors to further enhance their catalytic potentials 53. 6) Modified nucleobases. Nonnatural 
DNA/RNA bases can be incorporated to provide more functional groups 54. 
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1.1.3 Applications of Functional Nucleic Acids 
Due to the excellent recognition and binding ability, aptamers have become important 
tools in analytical chemistry. They have been used as affinity probes in capillary electrophoresis 
(APCE) for the detection and quantification of proteins and determination of binding parameters 
55-57. Detection of small molecule targets 58 and enantiomers 59 has also been accomplished in 
APCE. The use of laser-induced fluorescence (LIF) gives high sensitivity for detection. In 
addition, ultrasensitive detection of trace amounts of proteins has been realized by PCR 
amplifying the aptamer probes recognizing the protein targets 60. In this affinity-PCR technique, 
the signal can be amplified to improve sensitivity by several orders of magnitude (180 molecules). 
They can be immobilized onto the chromatography column and used as affinity stationary phases 
for liquid chromatography (LC) or capillary electrochromatography (CEC). Separation of 
different analytes 61-63, purification 64 and quantification 65 of the targets have been achieved using 
aptamer based affinity chromatography. Stereo-specific aptamers have been used for chiral 
separations as well 66, 67. In addition, aptamers used in affinity Matrix-assisted Laser Desorption 
Ionization-Mass Spectrometry (MALDI-MS) have been described 68, 69. 
Aptamers also have great potentials in clinical applications. Similar to DNA microarrays 
for genomic sample screening, aptamer microarray can be used for identification and 
quantification of protein samples for proteomics. Ellington group has demonstrated the use of 
aptamer microarrays for high throughput, parallel and rapid detection of multiple proteins using 
fluorescence scanning 70. Photo-aptamers selected that can covalently bond target proteins under 
UV radiation allow stringent wash and further advance the sensitivity and selectivity of this 
technique 71. Besides diagnostics, aptamers developed against disease-related targets to block 
specific sites and inhibit functions can become therapeutic agents. Aptamers targeting the 
vascular endothelial growth factor (VEGF) have been developed into drugs for treating age-
related macular degeneration 72. A number of other aptamer based drugs are currently in clinical 
trials 73. 
Similar to aptamers, catalytic nucleic acids can also be combined with other signal 
transduction elements to assemble analytical sensors 74. Ribozymes catalyzing in trans RNA 
cleavage reactions such as hammerhead ribozymes can potentially bind and cleave target mRNA 
in a catalytic manner and suppress target gene expression. Apparently, they can also act 
effectively using antisense-based suppression approaches as well. Theoretically, these ribozymes 
can be designed to cleave any RNA species (e.g. viral genome) and the specificity is determined 
by altering the substrate recognition regions. Therefore, they have been used in preclinical and 
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clinical studies as therapeutic solutions for treating cancers and HIV or viral infections 75-77. 
Ribozymes and deoxyribozymes can be used as potential biocatalysts for organic synthesis 78, 79. 
This is especially advantageous over traditional small-molecule catalysts when high selectivity is 
desired. 
 
1.2 SELEX 
1.2.1 History of SELEX 
In 1990, Tuerk and Gold isolated high affinity nucleic acids ligands against 
bacteriophage T4 DNA polymerase from a randomized RNA pool using a process referred to as 
Systematic Evolution of Ligands by EXponential Enrichment (SELEX) 80. They introduced 
completely random sequences for the eight loop bases of the wild-type 18 bases long hairpin 
mRNA encoding the target protein to construct the starting RNA library. These sequences were 
subjected to selection for binding to the polymerase target on nitrocellulose filters. The selected 
RNA sequences are reverse transcribed and amplified to double stranded DNA (dsDNA) and then 
transcribed to generate a new pool of RNA with enriched binding affinity for the next round of 
selection. Sequences with binding affinity similar to the wide-type hairpin have been evolved 
after four rounds of SELEX selection. Among the two predominant consensus sequences found, 
one is the wide-type sequence and the other one is a sequence with four different loop bases. 
They bind the polymerase with similar low Kd of 5 nM which is 100 times lower than the non-
specific RNA binding. 
Meanwhile, Ellington and Szostak used a similar in vitro selection method independently 
to select RNA sequences with high affinity for six small organic dyes 81. Instead of nitrocellulose 
filter partitioning, the RNA pool was subjected to affinity chromatography separation. Dye 
molecules were cross-linked to agarose beads in the column and binding sequences were also 
retained in the column upon binding the dyes and eluted later for collection. After four to five 
cycles, the abundance of bound sequences was enriched from less than 0.1% for the starting 
library to over 50%. Unlike the Gold’s work using a library containing partial randomized bases 
(65,536 variants), Szostak used a completely random synthesized pool with a larger number of 
sequences (1013 copies). Furthermore, the staring pool of the Gold’s study was randomized based 
on a known target binding sequence, while the library used in Szostak’s study had no apparent 
affinity for the targets. However, in their study, there was no competition for binding as the 
ligand was in access. 
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Figure 1.2. Schematic illustration of SELEX process 
 
The nitrocellulose filtration and affinity column methods have soon become standard 
SELEX procedures for selection of aptamers against many different target molecules over the 
past two decades. The nitrocellulose filter retains most of the proteins and thus can be used for 
selection against protein targets; while target molecules can also be immobilized to the affinity 
column by either covalent bonding or affinity tags and used for aptamer selection. 
1.2.2 Recent Progress in SELEX Methods 
Ever since the first introduce of SELEX, a number of new partitioning techniques have 
been employed in SELEX for more efficient and convenient selection, such as centrifugation, 
magnetic separation, surface plasmon resonance, flow cytometry, gel mobility shift, capillary 
electrophoresis and microfluidic devices. 
Centrifugation is a way to separate particles from liquid solution using gravity. When 
used in SELEX separation, the bound fraction is precipitated upon changing buffer composition 
or by immunoprecipitation and unbound sequences are removed with the supernatant. Rhie and 
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Tahiri-Alaoui have used centrifugation to co-precipitate the prion protein from Scrapie-associated 
Fibrils (SAF) with bound RNA sequences 82. Similarly, using a 5-20% sucrose gradient 
centrifugation, RNA variants binding bacteriophage Φ29 prohead were evolved 83. Homann has 
selected RNA aptamers against African trypanosomes using centrifugation as well 84. 
Magnetic beads can be easily handled and thus enable fast, efficient and even automated 
separation by use of a magnet to trap the bound sequences. Strehlitz has developed a technique 
named FLuMag-SELEX in which fluorescent labeled DNA library and target coated magnetic 
beads are used for aptamer selection 85, 86. Compared to the non-magnetic beads that require 
centrifugation separation, magnetic separation is a more efficient technology. A semi-automated 
SELEX using magnetic beads has also been developed 87. A robotic workstation with magnetic 
rods were employed to implement the collection of aptamer bound magnetic beads, wash and 
resuspension of bound sequences. Cox and Ellington further developed an automated platform for 
selection of RNA against an oligonucleotide by using complete robotic liquid and mechanical 
manipulations and a magnetic bead separator equipment 88.  
Surface plasmon resonance (SPR) has been broadly used to study biomolecular 
interactions to obtain both thermodynamic and kinetic information of binding events 89-91. It takes 
use of evanescent wave on the boundary of metal film and the liquid sample. The change of the 
reflection angle is determined by the local reflection index which is changed upon the adsorption 
or binding of ligand to the surface-coated targets. Misono and Kumar 92 have used SPR for 
simultaneous selection and affinity characterization of aptamers binding influenza virus 
hemagglutinin (HA). High affinity RNA aptamers have been selected after five cycles and 
conserved regions of the aptamers have been identified. In their study, the RNA library was 
injected onto a CM4 chip with immobilized target protein HA. Binding sequences were then 
dissociated and fraction collected upon washing the flow cell for reverse transcription, PCR 
amplification and next round of selection. The binding affinity of each round pool showed 
increased response on SPR with increasing rounds. In this way, binding ability of the sequences 
can be estimated even before they were selected. Similarly, aptamers binding HIV-1 gp120 SU 
glycoprotein have also been successfully selected using SPR and they have been proven to 
neutralize the HIV-1 infectivity by over 1,000-fold 93. 
Flow cytometry is a powerful and high speed technique to gain physical and chemical 
information of cells. When coupled with cell sorting instrumentations, it allows rapid cell/bead 
sorting and ligand identification from a large combinatorial library. Yang and Gorenstein 94 have 
done preliminary two-color flow cytometric aptamer selection against NF-κB p50 and p65 
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proteins. They constructed one-bead one-sequence oligonucleoside phosphorodithioate (ODN) 
library and the bead library was then incubated with protein targets for binding. A primary 
antibody binding the protein targets and a secondary labeled antibody binding the primary 
antibody were used to identify the beads with the binding sequences. Beads with high 
fluorescence intensity can be easily detected by flow cytometry and sorted into microcentrifuge 
tubes for PCR and sequencing. Blank and Schluesener 95 have used flow cytometry to monitor the 
progress of selection against YPEN-1 rat endothelial cells. The starting library contained ~1015 of 
DNA sequences with 60 random bases flanked by two 18-nt primer regions. Binding sequences 
were partitioned from unbound sequences using centrifugation. Starting from the second round, 
FITC label was added to the DNA via incorporating FITC labeled primer in PCR. This 
fluorescent label allowed the monitoring of the selection using flow cytometry. The selected 
pools showed progressive increase in fluorescence intensity of the bound cells. 
Gel electrophoresis separates compounds based on how fast they move towards the poles 
under electric field. The speed or electrophoretic mobility of individual molecule is determined 
by their sizes and charges. The highly negatively charged nucleic acids move towards the anode 
when applying separation voltage. The binding sequences form complex with protein targets and 
thus slow down the moving speed of these binding sequences resulting in up shift of bands from 
the unbound sequences. Afterwards, the binding sequences can be recovered from the gel band by 
crush-and-soak method and then amplified for next round of selection. A RNA pool was selected 
for their affinity for ScVL viral particles and investigated for their packaging and replication 
activities 96. The binding mixture was separated by agarose gel electrophoresis and the shifted 
band was excised and extracted for binding sequences. DNA sequences binding bacterial protein 
Integration Host Factor (IHF) were separated by nondenaturing polyacrylamide gel 
electrophoresis and the gel fragment was visualized under UV with ethidium bromide staining 97.  
Compared to gel electrophoresis, capillary electrophoresis has much higher resolution 
and thus is a more efficient separation technique. The electrophoretic mobility of nucleic acids 
changes greatly upon binding large protein targets. In CE-SELEX, equilibrium mixture of targets 
and nucleic acids were loaded onto a capillary. Upon applying high voltage, binding complex was 
separated from unbound sequences and migrated into the collection vial for amplification and 
next cycle. This technique also allows the binding and separation to take place in homogenous 
solution environment and minimizes non-specific interaction 98. DNA aptamers have been 
selected against human IgE 99, Neuropeptide Y 100 and HIV-RT 101 using CE-SELEX within only 
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2-4 rounds due to the high resolution of CE separation. However, the low loading capacity of the 
capillary may potentially limit the total pool size for selection. 
Microfluidics technology is gaining great attentions in aptamer selection as well as 
applications as it provides a miniaturized environment for high speed processing, low sample 
consumption and potential for automation. Using target coated magnetic beads, the Soh group has 
developed a microfluidic device named continuous-flow magnetic activated chip-based 
separation (CMACS) for SELEX selection of aptamers 102. An external magnet was used to 
magnetize the Ni strips embedded in the microfluidic channels. Magnetic beads with coated target 
proteins and bound DNA aptamers traveled from the edge sample stream to the center of the 
buffer stream by both the hydrodynamic force and magnetophoretic forces imposed and were 
collected into the center product outlet. The same group later developed an improved microfluidic 
device: micromagnetic separation (MMS) chip which utilized arrayed nickel strips in grids in the 
wide separation chamber to generate magnetic force and grasp the aptamer-bound beads 103, 104. 
Other than magnetic manipulation, an electrophoresis based separation technique, micro Free 
Flow Electrophoresis (µFFE) that combines the continuous sample injection and free solution 
separation in electrophoresis was also used for SELEX. High affinity DNA aptamers against IgE 
have been isolated after only 1 cycle using µFFE-SELEX 105. In µFFE, the analyte stream is 
introduced into the separation chamber longitudinally and deflected laterally by applying a 
separation voltage perpendicular to the flow direction of the analyte stream. In this way, 
continuous sample injection, separation and collection can be achieved. Another advantage of 
using microfluidics in SELEX is that different steps in SELEX can be carried out using different 
microfluidic parts and these parts can be put together to assemble an integrated and automated 
selection platform 106. Microfluidic separation and on-chip PCR amplification have been coupled 
together to make integrated device for SELEX selection of aptamers 107.  
Other than different partitioning methods used in SELEX, photoSELEX has been 
emerged as an innovative method to select aptamers with extreme high affinity and specificity. 
Jensen has used photoreactive chromophore 5-iodouracil in the RNA pool for isolation of 
aptamers against HIV Rev by nitrocellulose filter partitioning and denaturing gel partitioning 108. 
The isolated aptamers not only bind but also cross-link the protein target with long wavelength 
UV laser light treatment. UV radiation of 5-IU produces uracil-5-yl radical which reacts with 
aromatic amino acids and cysteine. DNA library with 5-bromo-2’-deoxyuradine (BrdU) was used 
for photoSELEX as well 109. This modified base specifically cross-links aromatic and sulfur-
baring amino acids after absorbing UV light radiation only in close proximity. The covalent 
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bonded binding complex allows the use of harsh washing condition and only aptamers binding 
the protein target tight enough and in close proximity can be selected.  
1.2.3 Selection of Catalytic Sequences 
Highly selective catalytic antibodies can be selected from a large library in the immune 
system by the transition state analog (TSA) method 110. The same strategy has been used to isolate 
ribozymes with catalytic activities. The method starts with the proper design of the transition state 
analog for the reaction of interest. Then a random pool of RNA molecules is screened for their 
affinity to the analog. Prudent et al. used the TSA method to isolate ribozymes catalyzing the 
isomerization of a bridged biphenyl 32. In 1996, Conn et al. found another ribozyme capable of 
catalyzing porphyrin metalation using the TSA approach 36. 
 
Figure 1.3. Schematic illustration of the in vitro selection of a RNA cleaving deoxyribozyme 111. 
The catalytic sequences can cut themselves from the column and collected for PCR amplification 
and further rounds of selection and enrichment. 
 
Another more popular approach is the direct in vitro selection method in which catalytic 
sequences can be separated from the other inactive sequences due to some kind of self-
modification of the active sequences as a result of the catalytic reaction. Bartel and Szostak used 
the direct selection strategy to isolate ribozymes catalyzing RNA ligation from a random pool of 
RNA molecules 30. A RNA pool is transcribed from a ligated DNA containing 220 random bases, 
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with all molecules beginning with a 5’-triphosphate group. Incubation of the RNA pool and the 
tagged substrate RNA leads to the ligation of catalytic sequences to the tagged substrates. The 
ligated active sequences can be retained by the oligonucleotide affinity column complimentary to 
the tagged sequence while the inactive sequences are washed away. The retained sequences are 
amplified for the next round of selection by selective polymerase chain reaction (PCR) 
amplification using a primer complementary to the tagged sequences. The in vitro selection has 
also been used for the discovery of a deoxyribozyme that cleaves RNA in the presence of Pb2+ by 
Breaker and Joyce 111. 
 
1.3 CE-SELEX 
1.3.1 Capillary Electrophoresis 
Electrophoresis and chromatography are two main techniques commonly used in 
analytical separation. Chromatography is based on the partitioning of compounds between two 
different phases; while electrophoresis describes the movement of charged particles under 
uniform electric field. Capillary electrophoresis (CE) taking use of a narrow fused silica capillary 
(20-150μm ID, 350-400μm OD) as the separation channel is now the modern type of 
electrophoresis for analytical separation 112. Compared to the traditional electrophoresis, the small 
diameter and the large surface area of capillary greatly reduce the Joule heating by fast 
dissipating heat. This allows the use of high voltage or electric field which improves the 
separation efficiency. A typical CE separation takes only seconds to a few minutes. The capillary 
can be filled with many separation media allowing multiple modes of CE separation to be carried 
out. Arrayed capillary electrophoresis further facilitates high-throughput analysis. 
 
Figure 1.4. Schematic illustration of capillary electrophoresis system 
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When migrating under electric field, charged particles experience two main forces, 
electric force (FE=qE) and friction force (Ff=6πηrv). The electric force and the friction force 
reach balance within a short time and the particles start to travel at constant velocities.  
 6𝜋𝜂𝑟𝜇𝑒𝑚𝐸 = 𝑞𝐸 1.1 
 
 𝜇𝑒𝑚 =
𝑞
6𝜋𝜂𝑟
=
𝑧𝑒
6𝜋𝜂𝑟
=
2𝜀𝜁
3𝜂
 1.2 
 
Here electrophoretic mobility (μem) is defined as the velocity under unit electric field. q is 
the charge of the particle, r is the hydrodynamic radius of the particle, η is the viscosity of the 
solution, ε is the dielectric constant of the solution, ζ is the electrokinetic potential or zeta 
potential of the infinitely diluted particle. So the electrophoretic mobility is an intrinsic property 
of the charge particle and it is determined by the particle’s charge to size ratio (q/r). Therefore, 
CE separation is based on the difference in electrophoretic mobility. 
Due to the dissociation of silanol groups (-Si-O-) in aqueous solutions, the capillary wall 
has fixed negative charges. These charges attract positively charged ions and result in a higher 
concentration of positive charges in relative to the bulk solution. These positive charges form the 
electric double layer. The Charges in the stern layer adsorb tightly with the surface and cannot 
move; while the diffusional layer or part of it can move at the slippery plane under electric field. 
They also exert forces on the solvent molecules nearby and drag the whole bulk solution to move 
to the same direction. This phenomenon is named electroosmotic flow (EOF). Therefore, the 
apparent velocity of the analyte is the sum of the velocity of the analyte itself and that of EOF. 
 𝜇𝑡𝑜𝑡𝑎𝑙 = 𝜇𝑎𝑛𝑎𝑙𝑦𝑡𝑒 + 𝜇𝐸𝑂𝐹 1.3 
 
 𝜇𝐸𝑂𝐹 =
𝜀𝜁𝐸𝑂𝐹
𝜂
 1.4 
 
The electrophoretic mobility of EOF is determined by the zeta potential of the capillary 
wall and is much greater than that of the analytes (𝜇𝐸𝑂𝐹 > 10𝜇𝑎𝑛𝑎𝑙𝑦𝑡𝑒) 
113. Therefore, all analytes 
are carried along with the bulk solution to the negatively charged cathode in the order of positive, 
neutral and negative charges. In this way, ionic analytes can be separated according to their 
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charge to mass ratio or electrophoretic mobility. Neutral analytes are not charged and thus 
migrate as a single peak. So the separation of neutral analytes requires additional mechanisms 
such as micellar electrokinetic chromatography (MEKC) that uses micelles as pseudo-stationary 
phase 114, 115. 
The peak broadening effect of any analytical separation techniques comes from the 
following processes: separation, injection and detection. 
 𝜎2 = 𝜎𝑠𝑒𝑝
2 + 𝜎𝑖𝑛𝑗
2 + 𝜎𝑑𝑒𝑡
2  1.5 
 
 𝜎2 = 𝜎𝐷𝐿
2 + 𝜎𝐷𝑅
2 + 𝜎𝑃
2 + 𝜎𝑇
2 + 𝜎𝐸
2 + 𝜎𝑖𝑛𝑗
2 + 𝜎𝑑𝑒𝑡
2  1.6 
 
The subscript sep, inj, det, DL, DR, P, T, E are referred to peak broadening effects from 
separation, injection, detection, longitudinal diffusion, radial diffusion or eddy diffusion, phase 
transfer, joule heating and electric field respectively. 𝜎𝑇
2  and 𝜎𝐸
2  are characteristic of CE 
separation. 𝜎𝑖𝑛𝑗
2  and 𝜎𝑑𝑒𝑡
2  are general terms. Phase transfer in CE is also minimal as it does not 
involve partitioning between two phases. So ideally in CE, longitudinal diffusion is the only peak 
broadening effect (𝜎2 ≈ 𝜎𝐷𝐿
2 ). Similar to chromatography, the separation efficiency of CE is 
characterized by theoretical plate number N or plate height H. 
 𝑁 =
𝐿𝑒𝑓𝑓
𝐻
=
𝐿𝑒𝑓𝑓
2
𝜎𝐷𝐿
2 =
𝐿𝑒𝑓𝑓
2
2𝐷𝑡𝑅
=
𝜇𝑉𝐿𝑒𝑓𝑓
2𝐷𝐿
 1.7 
 
Apparently, higher voltage (V), less diffusion (D) and greater mobility (µ) generate 
narrower peaks and higher column efficiency. However, high column efficiency does not 
necessary lead to good separation. Another parameter resolution (Rs) describing the degree of 
separation is also important. Resolution characterizes how two adjacent peaks are separated from 
each other. Under ideal conditions, 
 𝑅𝑠 =
2(𝑡2 − 𝑡1)
𝑤1 + 𝑤2
=
1
2
√𝑁(
𝜇1 − 𝜇2
𝜇1 + 𝜇2
) =
𝜇1 − 𝜇2
4√2
√
𝑉𝐿𝑒𝑓𝑓
𝐿𝐷(𝜇1 + 𝜇2)/2
=
Δμ
4√2
√
𝑉𝐿𝑒𝑓𝑓
𝐿𝐷?̅?
 1.8 
 
Therefore, the resolution also depends on the difference of electrophoretic mobility (Δµ). 
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1.3.2 Capillary Electrophoresis-SELEX 
Capillary electrophoresis has been extensively used to study aptamer-protein bindings 
previously and has been proven to be capable of separating the aptamers bound to the protein 
target from the free unbound aptamers with high resolutions 55-57. This naturally leads people to 
explore the possibility of applying CE for SELEX selection of aptamers. The first couple of CE-
SELEX selections were successfully performed against protein targets 99, 101, 116, 117. Not limited to 
large protein targets, CE-SELEX selection has been performed against a smaller peptide target - 
neuropeptide Y (NPY) 100. It consists of only 36 amino acids and has a molecular weight of 4272 
g/mol which is even smaller than the ssDNA itself (25 kDa). Aptamers with 300 nM Kd have 
been successfully selected using CE-SELEX after only 4 rounds of selection. Recently, CE-
SELEX selection against an even smaller compound – N-methyl mesoporphyrin (NMM, MW = 
588 g/mol) has been demonstrated 38. These studies have greatly expanded the scope of CE-
SELEX applications. 
In CE-SELEX, the ssDNA/RNA sequences are firstly heated and then cooled down to 
room temperature to allow them to fold into the most stable secondary and tertiary structures.  
Target molecules are added then with these sequences and incubated in free solution to achieve 
binding equilibrium. The concentration of target molecules is kept low to promote competition 
for sequences to bind. A few nanoliter of the equilibrium mixture is injected onto a separation 
capillary. The bound sequences are separated from the unbound sequence using free solution zone 
capillary electrophoresis under either equilibrium or non-equilibrium conditions. 
In free solution zone capillary electrophoresis separation, nucleic acid molecules carrying 
high density of negative charges have the highest electrophoretic mobility against the EOF and 
thus migrate off the capillary last. Targets usually carry less negative charges and migrate off the 
capillary before the DNA peak. Therefore, the binding complex has an intermediate mobility and 
comes off the capillary after the target peak but before the free DNA peak. The libraries are 
usually labeled with fluorescent dyes to facilitate detection with laser induced fluorescence (LIF) 
due to the ease of labeling chemistry for nucleic acids than proteins. Therefore, only the large 
excess of free DNA peak is observed and a blind collection of all components before the free 
unbound DNA peak is adopted for fraction collection. 
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Figure 1.5. Schematic illustration of the fraction collection in CE-SELEX. The binding complex 
migrates off the capillary before the free unbound ssDNA peak and is collected until the leading 
edge of the unbound peak reaches the buffer vial (tcollect). 
 
The collected bound sequence are then PCR amplified, purified and made single stranded 
again for the next round of selection. These steps repeat until there is no further improvement in 
binding affinity or sequence heterogeneity. Then the selected pools are made double stranded by 
PCR and ligated onto cloning vectors. The vectors containing selected sequences are transfected 
to Escherichia coli and individual colonies are raised. The plasmids are extracted and sequenced 
to obtain the specific sequence information for individual clones. 
Compared to conventional SELEX, aptamers are evolved after only 1-4 rounds using CE-
SELEX selection rather than 8-12 rounds for conventional SELEX. This greatly attributes to the 
high resolution of CE separation of bound and unbound sequences. Moreover, the free solution 
environment in CE-SELEX eliminates the necessity for negative selections against solid support 
and linker molecules for immobilizing target compounds and the nitrocellulose filter surface, 
which further simplifies and accelerates the process. In a direct comparison of CE-SELEX with 
conventional SELEX for selection against ricin toxin 118, after 9 rounds of selection, only 9.8% of 
the pool binds the target for the microtiter plate method and 38.5% of the pool binds for affinity 
chromatography SELEX. On the contrary, 87.2% binding abundance was achieved using CE-
SELEX after only 4 rounds of selection. 
 
1.3.3 Characterization of binding parameters 
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The dissociation constants (Kd) of selected sequences need to be assessed after each 
round of CE-SELEX to monitor the progress of the selection and evaluate the selected aptamers. 
Assuming a 1:1 binding ratio, the concentrations of the aptamer (A), the target (T) and the 
aptamer-target complex (C) are described in the following equations: 
 𝐴 + 𝑇 ⇌ 𝐶 1.9 
 
 𝐾𝑑 =  
[𝐴][𝑇]
[𝐶]
 1.10 
 
 𝑓𝑏 =  
[𝐶]
[𝐴] + [𝐶]
 =  
[𝑇]
𝐾𝑑  +  [𝑇]
 1.11 
 
fb here represents the bound fraction of the aptamers and Kd is the dissociation constant of 
the binding system. In two-ligand binding system, the concentration of one ligand is held constant 
(e.g. aptamer) and titrated with increasing concentration of another ligand. The bound fraction of 
the constant ligand can be measured by a number of analytical techniques and fitted with the 
concentration of the other ligand (e.g. protein) added to yield the Kd values. The total protein 
concentration [T]t is usually used as the free protein concentration [T] for the above equation. 
This requires the total aptamer concentration used to be lower than or equivalent to Kd so that the 
[T]t ≈ [T]. 
Like other SELEX selection methods, the separation technique itself can be used to 
measure the Kd values. The dissociation rate of the aptamer-protein complex is often slower than 
the CE separation time (koff << 1/tC) and thus the equilibrium composition of the complex is 
properly reserved after nonequilibrium separation. CE separation of the binding samples gives 
rise to two distinct peaks representing the binding complex and the free ligand (e.g. aptamer) 
respectively. As the protein concentration increases, the complex peak increases and the free 
aptamer peak decreases in both height and area, indicating an increase in the bound fraction. To 
couple with the CE-LIF detection, the aptamer is fluorescently labeled and the bound fraction can 
be calculated from the decrease in the free aptamer peak98 or the increase in the complex peak57 
quantitatively (𝑓𝑏 = 1 −
𝐼
𝐼0
  when I and I0 are the unbound aptamer peak in the presence and 
absence of targets, or 𝑓𝑏 =  
𝐼
𝐼0
 when I and I0 are complex peak at partial and fully bound. Due to 
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the loss of complex caused by wall-adsorption and dissociation, the free aptamer peak is more 
often used as an indicative of the bound fraction. 
If complex dissociation is significant during separation (koff ~ or >> 1/tC), kinetic 
parameters (rate constants kon and koff) can also be obtained in addition to the binding equilibrium 
constant (Kd or Ka) using so-called nonequilibrium capillary electrophoresis of equilibrium 
mixture (NECEEM) developed by the Krylov group 119-121. Since the run buffer does not contain 
either free aptamers or proteins under nonequilibrium condition, the complex dissociates as it 
migrates out of the equilibrium sample zone. The amount of aptamer dissociated from the 
complex decreases exponentially and forms an exponential decay curve following the free 
aptamer peak. This part can be fitted by a single-exponential curve to generate the dissociation 
rate constant koff assuming the quantum yield of the dye in the free aptamer and the complex is the 
same. 
 𝐼𝑡 =  𝐼𝑡𝐴  exp (𝑘𝑜𝑓𝑓
𝑡𝐶
𝑡𝐴 −  𝑡𝐶
(𝑡 −  𝑡𝐴)) 1.12 
 
tC, tA and t are the migration time for the complex peak, free aptamer peak and any time 
point on the exponential decay part. It and ItA are the intensity at time t on the exponential decay 
and the intensity of the free aptamer peak at tA. 
The binding constant (Ka) can be calculated using the peak areas of the complex, the 
exponential decay part and the free aptamer. Since 𝐾𝑑 =  
1
𝐾𝑎
=  
𝑘𝑜𝑓𝑓
𝑘𝑜𝑛
, the complete kinetic 
parameter profile can be revealed. 
 𝐾𝑎 =  
1 + (𝐴𝐶 + 𝐴𝑒𝑥𝑝)/𝐴𝐴
[𝑇]𝑡(1 + 𝐴𝐴/(𝐴𝐶 + 𝐴𝑒𝑥𝑝)) − [𝐴]𝑡
 1.13 
 
 𝑘𝑜𝑛 =  𝑘𝑜𝑓𝑓𝐾𝑎 1.14 
 
AC, Aexp and AA represent the peak area of the complex peak, the exponential decay and 
the free aptamer peak respectively. [T]t and [A]t are the total concentration of the target and the 
aptamer respectively. kon can be derived from koff and Ka. 
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The same group has developed another two kinetic CE (KCE) techniques named 
sweeping CE122 and plug-plug kinetic CE (ppKCE) 123, 124 for binding kinetic measurement. The 
SweepCE prefills the capillary with the low mobility ligand (e.g. aptamer) and applies 
electrophoresis from solution containing the high mobility ligand (e.g. protein). The high mobility 
ligand continuously binds the low mobility ligand and forms complex with higher mobility than 
the aptamer. Therefore, the aptamers are swept out of the capillary and the binding rate constant 
kon can be calculated using a mathematical model for the sweeping region. In the ppKCE method, 
the sample plug of the low mobility ligand are injected before the plug of the high mobility ligand 
onto the capillary. Upon applying separation voltage, the faster moving ligand passes through the 
slow moving ligand zone resulting in the formation of the complex. Continuing electrophoresis 
starts to separate the two ligand zones and dissociate the complex. Therefore, it better represents 
the kinetic processes of binding and dissociation (kon and koff); while the NECEEM describes the 
equilibrium status and then the dissociation process (Kd or Ka and koff). 
As opposed to fluorescence detection, label-free detection based on UV 124 and mass 
spectrometry 125 has been employed to eliminate the inconvenience of fluorescent labeling of 
aptamers. Moreover, with temperature control in CE, other thermodynamic parameters (ΔH and 
ΔS) of binding reactions can be revealed, as well as the dependence of kinetic parameters and 
equilibrium constant on temperature 126. 
Besides capillary electrophoresis, similar approaches are taken to separate the complex 
and the free ligands using other separation techniques, such as dialysis 127, ultrafiltration 128, 
HPLC 129 and gel electrophoresis (electrophoresis mobility shift assay (EMSA)) 130. The complex 
or free ligands are quantified and fitted to the binding isotherms to give the Kd values. Rather than 
separation based techniques, direct measurement of the binding mixtures is preferred as it better 
represents the equilibrium composition and avoids concerns regarding complex dissociation 
during separation. It also eliminates the time needed to separate binding mixtures and thus is 
much less time-consuming. In addition, binding measurements characterizing different properties 
of the analytes can be used as orthogonal techniques to confirm binding. 
If the fluorescence of the labeled aptamer changes upon binding the target 131-133 or the 
target itself is fluorescent and the intensity changes upon binding the aptamer 38, 134, both 
enhancement and quenching in the fluorescence intensity of the binding mixture can be used to 
estimate the binding affinity. The microenvironment of the dye can be significantly different 
when forming the apamer-target complex from in the free unbound status. For example, Li used 
an aptamer molecular beacon labeled with fluorophore and quencher on either end of the aptamer 
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for the Kd measurement of thrombin-aptamer binding 132. When in the absence of the target 
thrombin, the dual labeled aptamer takes random scrambled conformation and leaves the 
fluorophore and quencher separated, giving rise to fluorescence signal. With the addition of the 
thrombin, it binds the aptamer in a way that brings the fluorophore and quencher together and the 
fluorescence signal is quenched due to proximity. The opposite detection scheme has also been 
reported in which the quenched fluorescence signal is restored upon binding the thrombin 133. In 
addition, fluorescence resonance energy transfer (FRET) has also been employed for binding 
measurement as it provides a lower background noise and less false positive signal compared to 
molecular apamer beacon (MAB) 135. 
Another property of fluorescence, polarization, is also often impacted by binding 
interactions. For measuring fluorescence polarization (FP) or anisotropy, a polarized light is used 
to excite the fluorophore. The intensity of the emission fluorescence that are parallel and 
perpendicular to the excitation light are measured. The polarization (P) and anisotropy (A) are 
defined as below and they are basically mathematically interchangeable 136. 
 𝑃 =  
𝐼∥ −  𝐼⊥
𝐼∥ + 𝐼⊥
 1.15 
 
 𝐴 =  
𝐼∥ − 𝐼⊥
𝐼∥ + 2𝐼⊥
 1.16 
 
𝐼∥ and 𝐼⊥ represent the emission fluorescence intensity that’s parallel and perpendicular to 
the excitation light respectively. The measured polarization is determined by the following 
factors136: 
 
1
𝑃
−  
1
3
= (
1
𝑃0
 −  
1
3
) (1 +  
𝑅𝑇
𝜂𝑉
𝜏) 1.17 
 
P is the measured polarization and P0 is the limit polarization when there is no rotation. R 
is the universal gas constant, T is the absolute temperature, η is the viscosity of the sample, V is 
the molar volume and τ is the fluorescence life time of the dye. Target binding or complex 
formation causes the hydrodynamic volume V of the labeled ligand to increase and the 
polarization to increase as well. Actually 3ηV/RT is the Debye rotational relaxation time and 
larger complex usually has a longer rotational time because of the larger volume. Therefore, the 
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measured polarization or anisotropy can be used to calculate the bound fraction and the 
dissociation constant 137, 138. 
It is not uncommon when there are both fluorescence intensity and polarization changes. 
In such cases, the bound fraction calculated from fluorescent polarization measurement should be 
corrected for the fluorescence enhancement or quenching effect. For example, in the presence of 
fluorescence enhancement effect, the measured emission fluorescence comes more from the 
bound fraction and thus it contributes more to the polarization values. In other words, the 
measured polarization is proportional to the fluorescence intensity from the bound species. 
Therefore, the measured polarization value would be greater than in absence of that effect. This 
effect needs to be corrected using the following equations 139: 
 𝑄𝑚 =  
𝐼𝑚 −  𝐼0
𝐼0
 1.18 
 
 𝐹𝑏 =  
𝑃 −  𝑃𝑓
𝑃𝑏 −  𝑃𝑓
 1.19 
 
 𝑓𝑏 =  
𝐹𝑏
1 + 𝑄𝑚(1 −  𝐹𝑏)
 1.20 
 
where Qm is the fluorescence enhancement or quenching factor, Im and I0 are the 
fluorescence intensity of the fully bound and the free aptamer. Fb is the raw bound fraction 
calculated directly from the measured polarization (P), the polarization at fully bound (Pb) and 
polarization of free aptamer (Pf). It has to be corrected by the Qm factor to generate the real bound 
fraction fb. 
The fluorescent labeling of aptamers can sometimes affect their proper foldings and 
structures or change the binding affinity. Therefore, label-free techniques have been applied as 
alternatives. Surface plasmon resonance (SPR) measures the reflection angle of the evanescent 
light at the interface of the metal film and the liquid sample 89-91. Although it does not require 
fluorescent labeling, the aptamers still need to be immobilized onto the metal film. The angle 
shifted reflects the refraction index changes near the surface which is caused by the aptamers 
binding the target. The whole procedure includes baseline, association, dissociation, regeneration 
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and back to baseline. Therefore, it provides real-time monitor of the binding interaction and thus 
reveals the kinetic information 89, 91. 
Rather than the heterogeneous SPR, UV-vis adsorption provides a homogeneous 
measurement of the binding mixture. Binding affinity can be estimated from intensity changes of 
either aptamer or target peaks and the peak shift upon binding 140, 141. Circular dichroism (CD) is 
another UV-vis adsorption based technique that measures the differential adsorption of left and 
right circularly polarized light. Aptamer and protein are optical active or chiral molecules and 
thus showed signals in CD spectrum. Besides the basic primary structural information, the 
conformational chirality generates additional information in CD spectrum, yielding secondary 
and tertiary structure-specific spectrum. Therefore, the CD spectrum of aptamer before and after 
binding protein can be used to characterize binding affinity and further yield information on how 
the conformation changes 141, 142. 
Isothermal titration calorimetry (ITC) is another free solution technique that measures the 
heat released or absorbed for the binding reaction. One ligand is titrated with a series of addition 
of the other ligand in the sample cell and the electric power needed to keep the temperature as the 
same as another identical reference cell is measured. It not only generates dissociation constant 
Kd values 143, but also thermodynamic parameters (ΔG, ΔH and ΔS) 144 and even kinetic 
information 145. In this technique, the concentration of the ligand in the sample cell is kept in the 
range of 10 < c < 100 (c = n[ligand]/Kd, n is the binding stoichiometry) to get a good 
measurement of the binding isotherm 146. If the c is too small, the binding curve becomes too flat; 
while if the c is too large, it becomes too steep. For example, if the ligand concentration is too 
low, the heat released may not generate a sufficient signal for measurement. But on the contrary, 
if the ligand concentration is high enough to generate sufficient heat, it may be too high so that 
the binding isotherm becomes too steep. Therefore, ITC is not suitable for really tight binding 
(~pM Kd) and it also requires a lot more sample consumption. 
 
1.4 Single Enzyme Molecule Detection 
The lowest theoretical limit of detection one can reach is single molecule. The ability to 
detect single molecules removes averaging effect of ensemble bulk and reveals the small 
differences among individuals. This becomes important especially when dealing with biological 
macromolecules, such as proteins. In order to achieve detection at single molecule level, one 
approach is to interrogate the target molecules in extremely small volume. Both optical and 
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electric signals can be measured. Nanopores formed in lipid bilayers or synthetic membranes 
have been used to detect single molecules by monitoring the ionic current during their passage 
through the nanopores 147. When individual fluorescent molecules are probed in ultra-small 
interrogation volumes illuminated by a laser beam, high signal can be achieved to realize single 
fluorophore detection 148. This technology has now been used for single molecule sandwich 
immunoassays known as Singulex 149. 
Another approach to increase the limit of detection is to amplify the signal generated by 
the target molecules. Enzyme molecules have been employed to amplify signal by converting 
multiple fluogenic substrates into fluorescent products 150. In this way, detection of target 
molecules are achieved by detecting signal from the amplified fluorophores. Rather than indirect 
detection of the molecule of interest, another similar approach is to amplify the target molecule 
itself. An example is to take use of the nature of nucleic acids molecules that they can be 
amplified by PCR for detection of single DNA molecules 151. And lastly, the signal from each 
fluorophore is intrinsically amplified by cycling the photons through excitation-emission process. 
Since enzymes have the ability to amplify signaling molecules, they can be detected at 
very low concentrations. If enzyme molecules are further confined or trapped in ultra-small 
volumes, it adds extra sensitivity to the detection and eventually single enzyme molecules can be 
detected in various analytical instrument settings. The same concept can be extended to any 
species that can catalyze the production of suitable fluorophores. 
1.4.1 Capillary Electrophoresis Assays 
When a diluted enzyme solution is loaded into the capillary with the corresponding 
fluogenic substrate, individual enzyme molecules are capable of catalyzing the substrate 
molecules around it and generating fluorescent products. The number of peaks indicates the 
number of enzymes present in the entire capillary. The variation of the peak areas shows the 
differences in the activities among the enzyme molecules. Xue and Yeung have used this 
approach to study the differences in the chemical reactivity of individual lactate dehydrogenase 
(LDH-1) 152. The enzymes were identified by detecting the fluorescent product NADH converted 
from nicotinamide adenine dinucleotide (NAD+). They have attributed the heterogeneity of 
enzyme activities to different protein conformations. Craig and Dovichi have also used capillary 
electrophoresis to study alkaline phosphatase and focus more on enzyme kinetics 153, 154. Reaction 
rates and activation energies were measured in their papers and the heterogeneity was attributed 
to the different post-translational modification of the primary structures. The same group has later 
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studied β-galactosidase and also found microheterogeneity among individual enzyme molecules 
155. 
In this type of assay, the small channel of capillary serves as reaction vessel for 
individual enzymatic reactions to take place and the high sensitivity of laser-induced fluorescence 
enables the detection of fluorescent products produced by single enzyme. Due to the small inner 
diameter of the capillary channel, amplified products are still highly localized with the template 
molecules to realize the detection of single enzyme molecules. The signal amplification and 
fluorescent labeling steps can be integrated simultaneously on-line in the capillary. Although 
single molecule detection limit has been achieved in this technique, there are still some 
drawbacks. The generated products can still diffuse longitudinal to cause broadened bands and 
reduced concentrations. In addition, the number of molecules that can be loaded and thus 
monitored within the confined capillary is limited. 
1.4.2 Microwell Array Assays 
The array format of the microwells provides high-throughput and allows the observation 
of large number of individual enzyme molecules simultaneously. Physical confinement of 
isolated microwells can further limit the diffusion of generated fluorescent products and 
accumulate enough high concentrations of detectable products within a short period of time. Tan 
and Yeung have utilized femtoliter-sized microwells to monitor single LDH-1 and Os (VIII) 
metal ion catalysis 156. The microwells were made of either pores in polycarbonate membranes or 
silica vials fabricated using photolithography. The single enzyme molecules trapped in individual 
microwells were detected by imaging the array device using a laser-based optical microscope and 
a charge-coupled device (CCD) detection system. They have observed heterogeneous catalytic 
activities for the enzyme molecules but more similar activities for metal ion catalysis, indicating 
that the added structural degrees of freedom of protein enzymes affect their activities. This type 
of devices also allows for real-time monitoring of single molecules’ enzymatic activities. 
Similar device has been fabricated using soft-lithography on poly-dimethylsiloxane 
(PDMS) as well for single β-galactosidase studies 157. Molecule heterogeneity has been identified 
and the distribution of single enzyme molecules in microwells was found to follow Poisson’s law. 
Walt and co-workers have developed the microwell array assay using fiber-optics. The 
microarray of femtoliter-sized reaction chambers is created at the distal end of a glass fiber optic 
bundle by preferentially etching the core material relative to the cladding. After filled with the 
enzyme and substrate mixture, the microwells are sealed against silicon gasket 150 or immiscible 
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oil phase 158. In this way, enzyme concentrations can be measured by counting individual enzyme 
molecules as digital signals 150. Later, kinetic mechanisms 159, 160 and inhibition effects 161 of 
single enzymes have been studied using the same device. Walt has also further developed the 
microwell array into more versatile applications, such as digital ELISA 162, multiplexed ELISA 
163-165, and single oligo sequence detection 166, 167. 
1.4.3 Water-in-Oil Emulsion Assays 
Isolated reaction chambers can also be created by enclosing aqueous solution in an 
immiscible oil phase as water-in-oil droplets. Batman has created 0.1-40 µm droplets by spraying 
an aqueous solution containing the enzyme and the fluogenic substrate in silicon oil 168. Single 
enzyme molecules trapped in 14-15 µm droplets can be detected after 15hrs incubation at 37 °C. 
One difficulty using the above mentioned techniques is the retrieval or recovery of the 
positive molecules after identifying them. Similar difficulty is encountered for adding, mixing, 
splitting of the reaction content once the molecules are isolated in individual reaction chambers 
and the incubation period starts. Micromanipulation of these isolated single molecules is 
important when further application and treatment after screening are desired. Great efforts have 
been put into the single molecule manipulations 169, such as valves in PDMS devices 170 and 
microdroplet manipulation. Specifically for droplet-based micromanipulation, Noji group has 
developed a directly accessible femtoliter-sized droplet array on a hydrophilic-in-hydrophobic 
patterned surface 171. The droplet array is formed by covering the patterned surface with aqueous 
solution first and then with oil. Droplets of aqueous solution retains on the patterned surface and 
isolated by the oil phase. Since no solid walls are present, these droplets can be accessed from 
outside using micropipette. 
In addition to the droplet array formed on a surface, serial droplet array generated in 
narrow channels has also been developed as individual reaction chambers. Ismagilov group has 
utilized a PDMS device with a T-junction to generate monodispersed droplets in microfluidic 
channels 172. The dynamic of the droplet formation and the break-up of the two threads is 
dominated by the pressure drop across the droplet as it forms 173. The size of the droplets is 
determined by the width of the channel and the volumetric flow rates of two immiscible fluids. 
These microdroplets can then be further sorted and collected in microfluidic devices using 
dielectrophoretic actuation according to their fluorescence generated by enzyme activity 174. 
Compared to the surface array format, this serial array requires the droplets to pass through the 
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detection zone individually and results in longer assay time. However, the automated droplet 
detection and sorting devices enable the convenient and fast recovery of the positive droplets. 
 
1.5 Microfluidics 
Given the extremely small interrogation volume required by the detection of single 
enzyme molecules, micro- or nano- fabricated devices are essential for the ultra-sensitive 
measurement. Microfluidic devices usually have lateral feature dimensions on the order of 10-100 
µm. Simple two-dimentional devices usually contain only channel systems and more complicated 
three-dimentional systems even incorporate micropumps, valves and detectors on a single chip, 
which allows the manipulation of gases and liquids in a highly integrated and miniaturized 
microchip rather than labor intensive bench-top work. When compared with traditional 
macroscopic analysis systems, microfluidic systems possess many advantages. They require 
much smaller quantities of samples and reagents, which means decreased cost and minimal 
amount of waste. They provide faster, more automated and portable platforms for performing 
analyses and reactions. They can also be designed to achieve a high degree of multiplexing and 
high-throughput format. However, smaller features also make it more susceptible to blockage by 
particles and more non-specific adsorption to the surface. 
1.5.1 Materials and Fabrication 
Owing to highly developed techniques of microelectronics and micromachining, 
traditional microfluidic devices are usually fabricated on silicon and glass wafers. The features 
can be designed by the computer-aided design (CAD) program, and a chrome mask is used to 
transfer the designed features to the wafers. Using standard photolithography and subsequent wet 
etching of the wafers, microchannels can be fabricated on silicon and glass wafers. Another piece 
of wafer is then used to seal the device and form closed channels. However, silicon is not the 
ideal material for microfluidic applications. It is electrically semiconducting and thus proves to be 
problematic for use in analytical separations which usually apply high voltage to transport liquids. 
It is also optically opaque, which makes optical detection difficult. Glass is a transparent insulator 
and thus a preferred substrate material. The silanol groups (-Si-OH) can support electroosmotic 
flow (EOF) in electrophoresis separations. However, both materials are relatively expensive and 
require complicated fabrication procedures and clean room environment. The highest aspect ratio 
that can be achieved is limited by the wet etching method and dry etching technique of silicon is 
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expensive. Their surfaces are charged and the adsorption of biomolecules through electrostatic 
interactions or hydrogen bonding is problematic for bioanalysis. 
Polymer microfluidic devices are less expensive and easy to fabricate using mass 
replication technologies. They can be fabricated with high aspect ratio and the surface can be 
modified to meet various application requirements. The most commonly used polymer materials 
in microfluidics include poly (dimethylsiloxane) (PDMS), polycarbonate (PC), 
polymethylmethacrylate (PMMA), polyethylene (PE), polypropylene (PP) and polystyrene (PS) 
175. The most widely used replication method includes master fabrication and replication process. 
The master can be fabricated by micromachining 176, electroplating 175, silicon micromaching 177, 
solid object printing 178, and rapid prototyping method 179. The master then serve as a mold for the 
polymer replica by hot embossing 180, injection molding 177 and casting 179, 181, 182.  
1.5.2 PDMS Microchips 
Among all the polymer materials used in microfluidics, poly(dimethylsiloxane) (PDMS) 
is one of the most rapidly developing materials 183. It is an elastomeric polymer which contains 
weakly cross-linked polymer chains and can be stretched when applying an external force and 
return to its original state when the force is removed 184. As a result, it can be peeled off a mold 
without damaging the channels or the master. It is transparent and has a UV cutoff at 240nm 185, 
which allows the optical detection at a wide range of wavelengths. It can be readily sealed with 
other materials such as glass, polystyrene and PMMA. It is an electrical and thermal insulator, 
nontoxic, chemically inert, impermeable to water, commercially available and inexpensive. 
However, it is not solvent resistant. It is hydrophobic and does not support EOF. And it may 
introduce non-specific adsorption to the surface and easily trap air due to its permeability to gases. 
The Whitesides group has pioneered in a rapid prototyping method to fabricate 
microfluidic systems in PDMS, which used a photoresist master for replica molding and thus cut 
the cost drastically.179 It has proven to be efficient, rapid and cheap and has become a dominate 
technique in PDMS microfluidic fabrication. The master fabrication for rapid prototyping starts 
with the design of the features using a CAD program. The features are then printed to high-
resolution transparencies or chrome masks. The masks are used to transfer the design to 
photoresist spin-coated substrate wafers in contact photolithography. Following the development 
of the photoresist, masters composed of a relief of photoresist on the wafers are created. The 
PDMS prepolymer is supplied in two parts: a base and a curing agent. The vinyl groups (-C=C-) 
contained in the base can react with the silicon hydride groups (-Si-H) present in the curing agent 
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and form a cross-linked elastomeric solid 185. Once the photoresist master is ready, the PDMS 
prepolymer mixture is casted against it. The liquid PDMS prepolymer conforms to the shape of 
the master and replicates the features of the master with high fidelity (10nm). It is then cured at 
an elevated temperature. After the PDMS becomes solid, it is peeled off the master without 
damaging the master itself due to its elasticity and low surface free energy. This process can be 
repeated many times as long as the master remains intact. The photoresist patterns can last a very 
long time and the damage of the master usually comes from the breakage of fragile wafers or the 
poor adhesion of photoresist to the wafers. 
The cured PDMS can be sealed to a flat surface to form closed channels both reversibly 
and irreversibly. When a PDMS surface is brought into contact with another flat surface, it 
conforms to the surface via Van der Waals force and closes the channels. The reversible sealing is 
watertight, fast but does not withstand high pressure (< 5 psi) 186. It is easy to break the reversible 
sealing simply by peeling PDMS off the surface and reseal them many times. Irreversible sealing 
requires air plasma treatment of both surfaces 187. PDMS has repeating units of -O-Si-(CH3)2- and 
the methyl groups (-Si-CH3) can be oxidized by the plasma to form silanol groups (-Si-OH) 187, 188. 
The oxidized PDMS surface is then quickly brought into contact with another surface containing 
appropriate groups (-OH, -COOH, ketone for 1 min) 185, 186 to form -Si-O-Si- bonds and seal the 
two surfaces irreversibly.  Irreversible sealing is much more robust and withstands pressures of 
30-50 psi 186. PDMS can be sealed to a number of different materials, such as PDMS itself, glass, 
silicon, quartz, silicon nitride, polyethylene, polystyrene and glassy carbon 179. 
The native PDMS surface is uncharged and hydrophobic due to the silane groups (-O-Si-
(CH3)2). Therefore, it is difficult to fill the channels with aqueous solution and easy to generate 
bubbles. And the surface is subject to adsorption of hydrophobic species. Various surface 
modification methods have been developed to make PDMS microchips available for more 
applications, such as oxygen plasma treatment to alter the hydrophobic PDMS surface to 
hydrophilic 179, 189, dynamic surfactant coating 190 and covalent modification by catalyzed 
polymerization 191. In addition, phospholipid bilayers 192 and proteins 193 have been used to 
immobilize biomolecules to PDMS microchip surfaces. 
PDMS microfluidic devices have been widely used in bioanalytical researches. Native 181 
and modified 179 PDMS channels have both been used to do separate DNA fragments, amino 
acids and peptides. Array format of assays can be carried out in PDMS microchips to achieve 
high-throughput analyses 194. Chemical reactions 194, PCR 195 and immunoassays 196 can also be 
performed in PDMS devices. 
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1.6 Scope of Thesis 
Ever since the first introduce of CE-SELEX, it has become a widely used and efficient 
tool for aptamer selection. However, most of the selections were performed against large protein 
targets. Mendonsa et al. has demonstrated a CE-SELEX selection against a smaller NPY peptide 
target. We are trying to explore the applications of CE-SELEX for even smaller targets and other 
difficult targets for conventional SELEX. Chapter 3 describes CE-SELEX selection against a 
small organic compound, indicating an even lower size limitation for the targets. Chapter 4 
describes CE-SELEX selection against a fully intact membrane target, which is difficult to study 
using conventional SELEX. Furthermore, binding of aptamers and important protein biomarkers 
in cardiac muscle cells has been investigated using ACE and FP to study the therapeutic 
potentials of nucleic acids for treating heart diseases and the regulation mechanisms , which is 
discussed in Chapter 5. Besides aptamers, nucleic acids with catalytic activities are also of our 
interest. We are working on new strategies for catalytic nucleic acids detection and selection. 
Chapter 2 of the thesis describes a proof-of-concept experiment for the novel detection of 
catalytic nucleic acids using a single enzyme detection platform.  
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Chapter 2: Assessing the Abundance of Catalytic Nucleic Acids using Single 
Enzymatic Molecule Detection in a Microwell Array Device 
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2.1 Introduction 
Despite comprising of only four chemically similar subunits, single stranded DNA 
(ssDNA) and RNA molecules can fold into various complex tertiary structures to bind different 
targets and even catalyze specific reactions 1. Catalytic sequences have been successfully isolated 
by selecting for affinity towards a transition state analog of the reaction 32, 36, 110. However, this 
selection strategy is based on a binding event rather than a direct catalytic reaction. Therefore, 
this indirect selection strategy only reflects the rate enhancement through stabilization of the 
transition state but ignores other possible catalytic mechanisms, which may limit the discovery of 
true catalysts. In addition, the method depends greatly on the correct choice of the transition state 
analog and thus it requires prior understanding of the mechanism. Moreover, the synthesis of the 
analog can be difficult. In vitro selection methods that separate sequences upon attaching to or 
cleaving from solid support by catalytic activities has become a more popular technique for 
catalysts selection 30, 111. It discriminates catalytic sequences according to their ability to carry out 
real reactions. However, this method involves the self-modification of the catalytic sequence 
itself and thus can only be carried out in single turnover conditions. This contradicts the definition 
of catalysts which carry out multiple turnover reaction without being consumed or permanently 
modified. Therefore, it has only generated sequences with moderate rate acceleration, preventing 
the discovery of highly active catalysts. This method is also tedious, time consuming and 
expensive with no promise of successfully finding a new catalyst. Therefore, an ideal strategy 
would be to discriminate sequences according to their catalytic activities acting on free substrates 
with multiple turnovers. 
Besides the selection of catalytic nucleic acids, there are still a lot of fundamental 
questions about the catalytic ability of nucleic acids that needs to be addressed, such as the scope 
of reactions that can be catalyzed by nucleic acids, the abundance of catalytic sequences in a 
random library for any given reaction, and how fast they can proceed. Current emphases are 
mostly put on the selection of active sequences from large pools and no previous work has been 
done to assess the frequency of active sequences. However, it would be interesting to study the 
catalytic abundance and efficiency of random libraries. This would help us to obtain pre-
knowledge of the catalytic ability of nucleic acids before real selection of catalytic sequences and 
also conveniently test the prebiotic hypothesis. Such assessment would require discrimination of 
single catalytic sequences from large inactive ones. Considering the similarity of protein enzymes 
and ribozymes/deoxyribozymes, it would be an advantage to take use of single enzyme detection 
systems to study individual catalytic nucleic acid sequences. Various devices have been used to 
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achieve detection and characterization of enzymes at single molecule level by detecting 
fluorescent products generated in limited spaces as a result of enzymatic reactions 152, 154, 160, 171. 
Similar strategy can be used to detect rare catalytic sequences in a large random library. 
In this manuscript, we described an easy and convenient detection scheme that can be 
used to study catalytic nucleic acids. It can directly detect the catalytic products by isolated 
nucleic acid sequences acting on separate substrates with multiple turnovers. The method was 
firstly validated by the detection of single enzyme molecules as a model and then used to study 
the abundance, catalytic efficiency and functional range of nucleic acids. Large random libraries 
consisting of different RNA or ssDNA sequences have been incubated with fluogenic substrates 
in thousands of microwells fabricated in PDMS. The detection of catalytic sequences can be 
achieved by detecting fluorescent products generated by the active sequences. 
 
2.2 Experimental Section 
Chemicals and reagents 
β-galactosidase (aqueous glycerol suspension) from Escherichia coli was purchased from 
Sigma-Aldrich (Saint Louis, MO). It was diluted to 4.22 µM in phosphate buffer containing 100 
mM NaH2PO4 (Mallinckrodt, Paris, KY) and 1 mM MgCl2 (Mallinckrodt) with a pH adjusted to 
7.5, aliquoted and stored at -80 ºC. Fluorogenic substrate fluorescein-di-β-D-galactopyranoside 
(FDG) was obtained from Invitrogen (Grand Island, NY). AttoPhos substrate was purchased from 
Promega (Madison, WI). All samples and buffers used in nucleic acid experiments were prepared 
using nuclease-free water (Integrated DNA Technology Inc., Coralville, IA). The DNA library of 
80 bases long, the RNA library of 50 bases long, and the RNaseAlert substrate were also 
purchased from Integrated DNA Technology Inc. (Coralville, IA). Both the DNA and the RNA 
libraries consist of completely random sequences, which allows the assessment of the catalytic 
abundance in completely random libraries. 
Fabrication of the microwell array device 
The microwell array device was fabricated on poly(dimethylsiloxane) (PDMS) using the 
rapid prototyping method 179. A SU-8 photoresist SU-8 2010 (MicroChem Corp, Newton, MA) 
was spin-coated on a 4 inch Si wafer using the spinner CEE2 (Brewer Scientific, CA). After the 
soft bake, the photoresist was exposed to a UV light under the designed chrome mask using a 
contact aligner system MA-6 (Karl Suss, CA). Following the hard bake, the unexposed area was 
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removed by the developer propylene glycol monomethyl ether acetate (Sigma-Aldrich) while the 
exposed area remained on the Si wafer. The PDMS prepolymer (Sylgard 184, Dow Corning, MI) 
was then casted against the fabricated SU-8 master after it was treated in a fluorinated silane fume 
(tridecafluoro-1, 2, 2-tetrahydrooctyl)-1-trichlorosilane (United Chemical Technologies Inc, 
Bristol, PA). Following the baking at 60 ºC in an oven, the PDMS layer hardened and was then 
peeled off the master and cut into desired size with the microwell array in the center of the chip. 
Each piece of the cut chips had a total of 40,000 microwells and the wells were grouped into 8 
mm by 8 mm square. Each well was 10 µm in diameter and depth and they were 30 µm apart 
from each other. 
Imaging of the device 
The PDMS device was placed on a glass slide. A drop of fluorescein solution was 
pipetted onto the PDMS chip and another glass slide was pressed against the PDMS and squeezed 
the solution into the microwells. A SMZ 1500 stereomicroscope (Nikon Corp., Tokyo, Japan) 
mounted with an X-Cite 120PC metal halide lamp (EXFO Photonic Solutions Inc., Mississauga, 
Canada) and a QuantEM 512SC CCD camera (Photometrics, Tucson, AZ) were used to image the 
microchip. The microscope was equipped with an Endow GFP band-pass emission filter cube 
(Nikon Corp.) containing two band-pass filters (450-490 nm and 500-550 nm) and a dichroic 
mirror (495 nm cut-off). The entire instrument setup was enclosed in black fabric (Thorlabs, 
Newton, NJ). Image acquisition and data processing were accomplished by Micromanager 
software with Image J. 
Single enzyme detection 
The stock β-galactosidase was further diluted to a concentration so that on average there 
was less than one enzyme molecule in each well. The fluogenic substrate FDG was kept at 100 
µM. The reaction buffer was 100 mM NaH2PO4, 1 mM MgCl2 and 10 mg/mL bovine serum 
albumin (BSA). The BSA was added into the buffer to prevent enzyme adsorption to the PDMS 
wall and the resulting deactivation. After the FDG and the β-galactosidase were mixed in a vial, a 
drop of the mixture was immediately pipetted onto the microchip and the reaction mixture was 
sealed into the microwells by a glass slide. The microscope focused on 0.8 × 0.8 mm area (zoom 
8×) of the micowell array and images of the focused area on the microchip were taken every 20 
minutes during the incubation at room temperature. 
Catalytic nucleic acid detection 
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Two different nucleic acid libraries were used to determine the abundance and the 
catalytic diversity and efficiency of completely random libraries. One was an 80 nt long single 
stranded DNA (ssDNA) library and the other was a 50 nt long RNA library. Three different 
substrates: FDG, AttoPhos and RNaseAlert substrate were tested to study the possible catalytic 
activity of the random libraries. 100-500 µM library was mixed with the fluogenic substrate and 
the mixture was pipette onto the microwell array chip. The reaction mixture was then incubated in 
each microwell for 2 hours at room temperature and images were taken every 20 minutes. The 
reaction buffer was 50 mM Tris, 100 mM NaCl, 100 mM KCl, 50 mM MgCl2 and 0.05% Tween 
20 at pH 7.0. 
 
2.3 Results and Discussions 
Imaging of the detection system 
Figure 2.1a showed the image of the microwell array device enclosing 1 µM fluorescein 
under 8× zoom. These microwells were 10 µm in diameter and depth, and 40 µm apart from each 
other. They were grouped into 8 × 8 mm squares with 40,000 microwells and the solution was 
successfully filled into the PDMS wells upon squeezing by the glass slide. The distance between 
every adjacent two microwells was three times larger than the wells’ diameter to leave enough 
contact area between the PDMS and glass to ensure good sealing. Different concentrations of 
fluorescein solution was enclosed in the microwells and the intensity of the microwells was found 
to be proportional to the concentration (Figure 2.1b). The standard deviation of different wells’ 
intensities was less than 10% indicating a uniform filling of solutions using this method. The 
limit of detection calculated for fluorescein was 0.1 µM. 
In order to further test the integrity of the sealing, an argon ion laser expanded into a 
~150 µm wide line was employed to photobleach the center columns’ microwells in the array for 
5 minutes. Images of the photobleached area were taken periodically over 1 hour (Figure 2.1c and 
d). Clearly there was no cross-talk or diffusion of the fluorescein into the photobleached area 
from adjacent microwells for at least 1 hour, which proved the good sealing of the microwells. 
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Figure 2.1. Microwells are 10 µm in diameter and depth and 40 µm apart from each other, with a 
volume of 785fL. (a) Microwell array enclosing 1 µM fluorescein. (b) Fluorecence intensity of 
microwells at different fluorescein concentration. (c) Image taken immediately after laser 
photobleaching. (d) Image taken 1 hour after photobleaching. 
 
Single enzyme detection 
β-galactosidase is a 465 kDa enzyme that catalyzes the hydrolysis of β-galactosides. Non-
fluorescent substrate fluorescein-di-β-D-galactopyranoside (FDG) can go through a two-step 
hydrolysis catalyzed by β-galactosidase to form highly fluorescent products fluorescein-mono-β-
D-galactopyranoside (FMG) and fluorescein. In the experiment, single enzyme molecules were 
incubated in individual microwells with excess substrates. Due to the small volume of the 
microwells, only 473 turnovers were enough to produce detectable amount of fluorescent 
products which can further be localized in the confined space in the microwells and the detection 
can be made in a relatively short period of time. Nonspecific adsorption to the highly 
hydrophobic PDMS surface can be a big problem for proteins especially for detection at single 
molecule level. A number of methods were used to prevent nonspecific adsorption of proteins to 
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PDMS 197-200. Here, a concentrated BSA solution (10 mg/mL) was added to the reaction buffer to 
block the large surface area of the PDMS wall in the small microwells with such high surface to 
volume ratio to prevent enzyme adsorption and deactivation. 
When 1.05 pM β-galactosidase was applied into the 785 fL microwells, on average there 
was 1 enzyme molecule in every 2 microwells. But statistically the enzyme molecules’ 
distribution would result in a few microwells with more than 1 molecule and therefore more 
empty wells. After 1 hour’s incubation at room temperature, 481 microwells were imaged and 
134 of them (27.9%) became fluorescent while the others remained dark (Figure 2.2a and b). The 
distribution of enzyme molecules in the microwells should follow a Poisson distribution 
considering the limited number of enzyme molecules compared to the wells: 
 𝑃 (𝑛, 𝜆) =  
𝜆𝑘𝑒−𝜆
𝑛!
 2.1 
 
where the λ is the average number of enzymes in each microwell (0.5 in this case) and n is the 
actual number of enzymes in these wells. So theoretically the percent of the total fluorescent 
wells should be 39.3%. This is close to the experimental result which is 27.9%. From the 
histogram, we noticed that the fluorescence intensity of the microwells covered a broad range but 
could be grouped into four distinct distributions. The four peaks were evenly spaced in the order 
of increasing fluorescence intensity and represented the microwells with zero, one, two and three 
enzymes respectively. More specifically, the percentage of peak area for 0, 1, 2 and 3 enzyme 
molecules were 71.2%, 24.6%, 3.5% and 0.7%. Those were in good agreement with the 
percentages predicted by Poisson’s law which were 60.7%, 30.3%, 7.6% and 1.3%. Images of the 
microwell array and the histograms of the fluorescence of the wells using different enzyme 
concentrations were summarized in Figure 2.2. They showed similar distinct peaks and obeyed 
the Poisson’s distribution. Furthermore, the broad distribution of the intensity under a single peak 
indicated the high heterogeneity of the activity of different enzyme molecules and the bulk 
activity is the average of all the individual enzyme molecules. 
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Figure 2.2. Images after 1 hour incubation of 100 µM FDG and β-galactosidase at enzyme to 
well ratio (a) 1:2, (c) 1:5 and (e) 1:10. Histograms showing the distribution of enzyme 
populations at enzyme to well ratio (b) 1:2, (d) 1:5 and (f) 1:10. A control was performed using 
only the substrate without enzyme and no fluorescent wells were observed. 
 
The reaction kinetics of individual enzyme molecules trapped inside the microwells were 
also studied by taking images of the microwell array over time. The fluorescence intensity in 
individual microwells was recorded and analyzed. Considering the single enzyme environment in 
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the microwells, there is an excess of the substrates and the enzyme is always saturated. Figure 2.3 
showed that the fluorescence continuously increased linearly over time in individual wells which 
proved a saturated enzymatic activity and the fact that the enzyme molecules were not inactivated 
by surface adsorption during the incubation. There were three different types of microwells with 
distinct reaction rates (slopes). The bottom trace showed no increase in fluorescence indicating an 
empty microwell without any enzymes. The three traces in the middle shared similar increasing 
rates in fluorescence and represented microwells with only one enzyme molecule. The top trace 
with the reaction rate of as twice as the middle traces were the microwells with two enzymes. 
 
 
 
 
 
 
 
Figure 2.3. Kinetic measurement of individual enzymes. (a) Five representative microwells were 
selected and numbered in white squares. 100 μM FDG was incubated with 0.42 pM β-
galactosidase (1 molecule in every 5 microwells) at room temperature. Image was taken after 
82min incubation. (b) Intensity of the selected microwells was plotted for the 2 hours’ incubation 
period. The numbers above the trajectories indicated the number of enzyme molecules in 
corresponding microwells: No.1 well contains two enzyme molecules; No.2, No.3, and No.4 
contain one enzyme molecule; No.5 well contains no enzymes. 
 
Catalytic nucleic acid detection 
After validating the detection system using single enzyme experiments, random nucleic 
acid libraries were used to determine the abundance of possible ribozymes (for RNA libraries) 
and deoxyribozymes (for ssDNA libraries). High concentration of nucleic acid libraries (up to 
500 µM or 2×108 molecules per well) were used to increase the number of incubated sequences 
and accordingly the chance of detecting catalytic sequences. Sufficient metal ions were added 
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into the reaction buffer to help possible foldings and catalytic activities of the nucleic acids. In 
previous discovery of catalytic nucleic acids, the active sequences were selected either based on 
binding the transition state analog32, 33, 36, 37, 39 or as a participant in a single turnover reaction27-31. 
Therefore the sequences were not selected directly according to the definition of enzymes which 
should carry out multiple turnover reactions without changing themselves. This might limit the 
discovery of real and fast ribozymes or deoxyribozymes. However, in the method reported here, 
only sequences that can convert multiple fluogenic substrates into fluorescent products can be 
detected and quantified. And this would allow the discovery of real catalytic sequences acting on 
separate substrates free in solution with multiple turnovers. 
Three different enzymatic reactions were studied using three different substrates. 
RNaseAlert substrates were used to test the ribonuclease activity. FDG was used to study β-
galactosidase activity and AttoPhos substrates were for alkaline phosphatase activity. These 
enzymatic systems were chosen as most known ribozymes/deoxyribozymes catalyze reactions 
involving phosphodiester bonds. Unfortunately, no fluorescent microwells were detected for all 
three substrates and two random libraries even after two hours’ incubation, indicating no catalytic 
sequences were present in these microwells. Figure 2.4 shows a typical image after incubating 
ssDNA or RNA library with one of the above fluogenic substrates. The total volume of imaged 
area was about 380 pL and the total number of sequences enclosed was up to 1.0 × 1011. The 
PDMS device can further be moved around to take images of all the microwells on the chip so the 
total number of sequences can even reach as high as 1.0 x 1013. The limit of detection for the 
three fluorescent products was measured to be 0.043 µM for RNaseAlert, 0.066 µM for FDG and 
3.46 µM for AttoPhos. Considering the incubation time, single catalytic sequence with rate 
constant greater than 2.8 s-1, 4.3 s-1 and 227 s-1 would have generated fluorescent products above 
these LODs. So we can conclude that there are no sequences with a catalytic rate at these levels 
among the incubated 1013 sequences for RNase, β-galactosidase and alkaline phosphatase 
activities and the corresponding substrates. It indicated that we would need to study much larger 
random libraries if we were looking for any catalytic sequences from a completely random library 
for comparable turnover rates for these activities or larger sequences are necessary to make the 
necessary structures for catalysis. This preknowledge of the abundance and catalytic efficiency of 
nucleic acid catalysts in a random library would also be of great importance for the design of 
future selection experiments. 
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Figure 2.4. Image of microwell array after 2 hours incubation of: (a) 1 µM RNaseAlert substrate 
with 100 µM ssDNA library. (b) 100 µM FDG substrate with 100 µM ssDNA library. (c) 300 µM 
AttoPhos substrate with 100 µM ssDNA library. 
 
2.4 Conclusions 
In this work, detection of single enzyme activity has been achieved by monitoring the 
conversion of a non-fluorescent substrate into a highly fluorescent product using a microwell 
array device fabricated in PDMS. This demonstrated the feasibility of extending the strategy to 
any similar reactions generating multiple copies of fluorophore and catalyzed by a single 
molecule which works exactly like an enzyme. It is the case for the study of catalytic nucleic 
acids in a large random library where there may be only one copy of each sequence. However, 
among the three enzymatic activities studied, we didn’t detect any fast catalytic sequences (kcat 
greater than 1 s-1) in 1013 random sequence ssDNA or RNA libraries. This indicates either less 
abundant active sequences or sequences with lower catalytic rates should be expected for those 
studied enzymatic activities in a random library. To further detect if there are any catalytic 
sequences with a lower turnover rate in a larger library, simultaneous monitoring of numerous 
ultrasmall reaction chambers and longer incubation time should be employed. Such assays have 
been made possible recently by advantages in microfluidics, especially droplet-based devices201-
203 and single cell/enzyme analysis research171, 204, 205. Future work will be focused on taking use 
of microdroplets as the reaction chambers to enclose larger number of sequences and provide 
longer incubation times and droplets containing catalytic sequences are expected to be detected 
and even collected for further isolation and sequencing. 
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Chapter 3: Capillary Electrophoresis-SELEX Selection of Catalytic DNA Aptamers 
for a Small-Molecule Porphyrin Target 
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3.1 Introduction 
Aptamers are single stranded DNA (ssDNA) or RNA sequences that bind targets with 
high affinity and specificity. They are selected in vitro through a process referred to as systematic 
evolution of ligands by exponential enrichment (SELEX).80 In the SELEX process, iterative 
rounds of separation of bound sequences, PCR amplification and purification are employed to 
evolve aptamers with high affinity. Recent technology advancement has brought in a more 
efficient and free-solution SELEX technique named CE-SELEX which uses capillary 
electrophoresis as the means of separation.98, 99 However, CE-SELEX has been previously only 
used for isolating aptamers for large protein targets99, 101, 116, 117 as it requires the aptamers to 
undergo a large mobility shift upon binding the targets. In a recent study, aptamers for a small 
peptide target neuropeptide Y (4272 Dalton) which is even smaller than the DNA itself (25 KDa) 
have also been successfully selected using CE-SELEX in only four rounds indicating the 
potential of using CE-SELEX for small molecule targets.100 In the case of small molecule targets, 
the mobility of the complex is expected to be changed only minimally from the non-binding 
sequences, resulting in only partial separation of the bound and unbound sequences. However, 
due to the fact that nucleic acids can be exponentially amplified by PCR, even if only a small 
portion of the complex can be collected, satisfactory enrichment can be achieved. Moreover, 
under the case of separation with low resolution, multiple iterative rounds of enrichment can still 
eventually evolve a high abundant pool with high affinity aptamers.206 
In this chapter, we describe using CE-SELEX to select DNA aptamers for a small 
molecule target: N-methyl mesoporphyrin Ⅸ (NMM). NMM is a small organic compound with a 
molecular weight of only 580 g/mol which is nearly an order of magnitude smaller than 
neuropeptide Y. To our knowledge, CE-SELEX has never before been used to isolate apatamers 
for such small targets. Figure 3.1 illustrates the chemical structure of NMM. It takes a distorted 
planar structure due to the presence of the methyl group. The bent aromatic ring system mimics 
the transition state of the porphyrin during metallation and inhibits the corresponding metal 
insertion reaction catalyzed by porphyrin chelatase.207 Both RNA36, 208 and DNA37, 209, 210 aptamers 
have been selected for NMM previously using affinity columns and found to be catalytic for 
porphyrin metallation reactions. We are now using CE-SELEX for the selection of NMM 
aptamers to investigate the limit of this technique in selecting aptamers with affinity for small 
molecule targets. 
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Figure 3.1.Chemical structure of the target N-methyl mesoporphyrin Ⅸ (NMM), MW=580g/mol 
 
3.2 Experimental Section 
Chemicals 
N-Methyl Mesoporphyrin IX (NMM) was purchased from Frontier Scientific Inc. (Logan, 
Utah). The ssDNA library used for selection consisted of 40 random bases flanked by two primer 
regions (5’-AGC AGC ACA GAG GTC AGA TG (40 random bases) CCT ATG CGT GCT ACC 
GTG AA-3’). The ssDNA library, primers and selected aptamers were all synthesized by 
Integrated DNA Technologies, Inc. (Coralville, IA). dNTPs and 25 bp DNA ladder were obtained 
from Life Technologies (Grand Island, NY). Taq polymerase and ThermoPol buffer were 
obtained from New England Biolabs (Ipswich, CA). The gel loading dye was from Promega 
(Madison, WI). All other chemicals were purchased from Sigma-Aldrich (St. Louis, MO). All the 
samples and buffers were prepared using 0.2 µm membrane filtered water from Milli-Q water 
purification system (Millipore Corp., Billerica, MA). 
Capillary electrophoresis selection 
Before selection, ~100 µM ssDNA library was heated to 72 °C for 10 min in TGK buffer 
(25 mM Tris, 192 mM glycine, 5 mM KH2PO4, pH 8.3) and cooled down to room temperature. 
The target NMM was then added to the library to a final concentration of 1 µM for the first round 
and 100 nM for subsequent rounds of selection. The ssDNA library was allowed to incubate with 
the NMM at room temperature for at least 20 min to ensure that the binding reached equilibrium. 
Capillary electrophoresis selection was performed using a 40.2 cm-long (with 30 cm to 
the detector), 50 µm-inner diameter, 360 µm-outer diameter uncoated fused silica capillary 
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(Polymicro Technologies, Phoenix, AZ) on a P/ACE MDQ capillary electrophoresis system 
(Beckman Coulter Inc., Fullerton, CA). The capillary was first rinsed with 0.15 M NaOH and 
then the TGK buffer for 4 min under 30 psi pressure before injection of the incubation mixture at 
1 psi for 4 s. The mixture was separated under 30 kV voltage (normal polarity) in TGK buffer at 
25 °C and the separation was monitored under UV absorbance detection at 254 nm. The NMM-
aptamer complex migrated off the capillary before the unbound ssDNA and was collected into a 
vial containing 48 µL separation buffer at the capillary outlet. After collecting the bound 
sequences, the voltage was turned off and the unbound sequences were washed off the capillary 
into a waste container using high pressure. 
PCR amplification and ssDNA generation 
The collected sequences were then PCR amplified to generate a new pool for the next 
round of selection. The PCR reaction master consisted of 200 µM dNTPs, 510 nM forward 
primer (5’-AGC AGC ACA GAG GTC AGA TG-3’), 510 nM biotinylated reverse primer 
(5’/biotin/-TTC ACG GTA GCA CGC ATA GG-3’), 0.025 unit/uL Taq polymerase and 7.5 mM 
MgCl2 in 1x ThermoPol PCR buffer (20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM 
MgSO4, 0.1% Triton X-100, pH 8.8). The high magnesium concentration helped improve the 
PCR efficiency of amplifying such a low concentration of the collected bound sequences. 20 
cycles of denaturation (94 °C, 30 s), annealing (53 °C, 30 s) and extension (72 °C, 20 s) were 
performed and followed by a final 5 min extension period at 72 °C. The length and the yield of 
the PCR products were verified and estimated using electrophoresis on a 1.5% agarose gel stained 
with ethidium bromide and imaged using a UV transluminator (Spectroline, Westbury, NY).  
The PCR products were purified and made single stranded using a streptavidin agarose 
resin (Pierce Biotechnology, Rockford, IL) and chromatography column (Bio-Rad, Hercules, CA). 
The PCR products were first incubated with streptavidin agarose resin in binding buffer (10 mM 
Tris, 50 mM NaCl and 1 mM EDTA, pH 7.5) for 30 min with periodical shaking. The column 
was then washed 10 times with 1 mL buffer to remove the PCR reagents while the amplified 
dsDNA was retained on the column through the interaction between streptavidin and the 
biotinylated strand. The desired forward DNA strand was eluted out of the column by incubating 
with 0.15 M NaOH for 10 min at 37 °C and desalted and concentrated by ethanol precipitation. 
Dissociation constant Kd measurements 
Dissociation constants Kd were measured by monitoring the increase of the fluorescence 
intensity of NMM after binding the aptamers140, 211. Aptamers of varying concentrations were 
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mixed with 500 nM NMM after 10 min annealing at 72 °C and slowly cooling down to room 
temperature in TGK buffer. The fluorescence intensity of 15 µL of each mixture sample was 
measured in a 384-well microplate (Corning Inc., Corning, NY) using a Synergy 2 Microplate 
Reader (BioTek, Winooski, VT). Fluorescence was excited using a tungsten lamp with a 360/40 
nm filter and measured at 610 nm emission. The net increase of the fluorescence intensity was 
then plotted against the aptamer concentration and the dissociation constant Kd can be determined 
by fitting the binding curve using the following equation: 
 𝐼 −  𝐼0 =  
𝑝[𝑎𝑝𝑡𝑎𝑚𝑒𝑟]
𝐾𝑑 + [𝑎𝑝𝑡𝑎𝑚𝑒𝑟]
 3.1 
 
where I and I0 are the fluorescence intensity of NMM in the presence and absence of aptamers 
respectively. Dissociation constant Kd and another constant p were obtained by non-linear fitting 
using the Origin v8.5 (OriginLab Corporation, Northampton, MA). 
DNA cloning and sequencing 
ssDNA sequences were cloned after 3 rounds and 6 rounds of selection using a TOPO 
TA Cloning kit from Invitrogen (Grand Island, NY). Aliquots of the two selected pools were PCR 
amplified under the same conditions described previously except using non-labeled reverse 
primer and 10 min final extension period. The PCR products were ligated onto pCR4-TOPO 
vectors and transformed into TOP10 Chemically Competent E.coli cells. Individual colonies were 
randomly picked and cultured in liquid LB broth (Invitrogen, Grand Island, NY) after growing 
the cells for 24 hours on a LB plate at 37 °C. Plasmid vectors containing selected sequences were 
extracted from the cells after overnight growth in LB broth at 37 °C using the plasmid miniprep 
kit from Invitrogen (Grand Island, NY). The vectors were sequenced by the BioMedical 
Genomics Center at the University of Minnesota (St. Paul, MN) using the T7 promoter primer. 
Catalytic activity measurements 
The initial rate of Cu (Ⅱ) insertion into mesoporphyrin Ⅸ (MP) catalyzed by selected 
aptamers was measured by monitoring the absorbance at 561 nm of the reaction mixture in a clear 
96-well microplate (Corning Inc., Corning, NY) using the Microplate Reader. 5 µM of the 
selected aptamers were initially annealed at 72 °C in kinetics buffer (25 mM Tris-OAc, 25 mM 
KCl, pH 7.5) for 10 min. After slowly cooling down to room temperature, Triton X-100, dimethyl 
sulfoxide (DMSO) and the MP were then added to final concentrations of 0.5% (w/v) Triton X-
100, 1% (v/v) DMSO and 100 µM MP. The mixture was allowed to equilibrate for more than 20 
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min at room temperature before the addition of 200 µM Cu(OAc)2 to initiate the reaction. The 
reaction rate was calculated according to the molar absorption difference (ε = 18.6 mM-1cm-1)212 
of MP and its product Cu-mesoporphyrin Ⅸ (Cu-MP). The UV absorbance spectra of MP and 
Cu-MP were also measured using the Microplate Reader. Cu-MP was synthesized by incubating 
200 µM Cu(OAc)2 with 100 µM MP in dark for 24 hours. 
 
3.3 Results and Discussions 
CE-SELEX selection 
Figure 3.2 illustrates the overall selection scheme of CE-SELEX. Briefly, a random 
ssDNA library containing 1012-1013 sequences is incubated with a low concentration of target in 
free solution followed by CE separation. The bound sequences are separated from the unbound 
sequences and collected for PCR amplification. The bound fraction is thus enriched and then 
purified and made single stranded again for next round of selection. This process repeats until 
there is no more affinity improvement in the selected pools. Finally the sequences can be 
determined by cloning and sequencing the selected pools. 
 
Figure 3.2. Schematic illustration of CE-SELEX process. 
 
In the presence of electroosmotic flow (EOF), the unbound ssDNA migrates off the 
capillary as a single peak while the aptamer-NMM complex would be expected to migrate off the 
capillary earlier due to the larger size and lower electrophoretic mobility. Due to the small size of 
NMM, the change in the electrophoretic mobility of the ssDNA upon binding the target is 
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expected to be small and the complex may not be completely resolved from the unbound peak. 
Taking this into account a collection window was chosen immediately before the leading edge of 
the free ssDNA peak (see Figure 3.3). The single peak observed in the electropherogram is the 
large excess of unbound ssDNA.  Binding sequences were collected up to the time point marked 
with the arrow. We anticipate CE-SELEX would be successful even if the bound and unbound 
ssDNA are not completely resolved since the leading edge of the unresolved peak would be 
biased toward the bound sequences.  In this case more rounds of selection may be necessary to 
fully enrich the ssDNA pool with binding aptamers. 
 
Figure 3.3. Selection electropherograms for: a) 1st round of selection and b) 2nd round of selection. 
The selection electropherograms for rounds 3 through 6 are similar to the 2nd round. 
 
The affinity of the enriched pool was assessed after each round to determine if further 
rounds of selection were needed. Previously reported aptamers for NMM are capable of 
increasing the fluorescence of NMM by over 20-fold upon binding140, 213. Therefore a similar 
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fluorescence assay was chosen to assess the affinities of the selected pools for NMM. The 
dissociation constants of aptamers for small molecules such as NMM typically range from the 
high nanomolar to low micromolar range2, 36, 208, 209.  The amount of ssDNA recovered after each 
selection round was limited, preventing us from obtaining a complete binding curve with the M 
NMM concentrations necessary to saturate the aptamers. Instead, the fluorescence of only one 
sample containing 500 nM NMM and 2-fold diluted (~1 µM) ssDNA from each selected pool 
was used to estimate the binding affinity. Figure 3.4 shows the normalized fluorescence intensity 
of NMM upon binding each selected pool. From the 1st round through the 4th round, the affinity 
of the selected pools improves with increasing rounds of selection. After 3 rounds of selection, 
the fluorescence of the complex increases by over 2-fold. However, after 4 rounds of selection, 
instead of increasing, the overall fluorescence intensity decreases slightly for the 5th and 6th 
rounds. This indicates there is no more affinity improvement for 5th and 6th round of selection. 
 
Figure 3.4. Normalized fluorescence intensity of NMM upon binding each selected pool. The 
first column is the fluorescence intensity of native NMM in the absence of ssDNA.  All other 
measurements were normalized to this control. Error bars represent the standard deviation. 
 
The ssDNA pools from the 3rd and 6th rounds were cloned and sequenced after the 
selection. 20 sequences from the 3rd round pool and 35 sequences from the 6th round pool were 
identified. The detailed sequence information is summarized in Table 3.1. 20 aptamer sequences 
were obtained for selection round 3. 36 clones were sequenced for round 6 but clone 6.16 failed. 
Therefore, only 35 sequences from round 6 are listed below. Note that sequence heterogeneity in 
the pools remains high throughout the selection, a characteristic common for CE-SELEX.  
 49 
 
Although no single common sequence motif was identified, we observed that the sequences from 
the 3rd round pool all contain 30-40% guanines, which is statistically higher than the 25% 
percentage predicted in a random library. 80% of the sequences have 4 continuous guanines (-
GGGG-) and 40% of sequences have 4 double guanines (-GG-) sequences. This suggests that 
these sequences are potentially capable of forming either inter- or intra-molecular G-quadruplex 
structures. This feature is in good agreement with previously selected NMM aptamers, which also 
adopt G-quadruplex structures140, 209, 214. However, the sequences from the 6th round deviate from 
the previous trend with only 8% -GGGG- and 17% four double guanines (-GG-) in a given 
sequence. The overall percentage of guanine in one sequence also drops to 25%. We attribute this 
deviation to the difficulty PCR amplifying sequences with high guanine percentages. It was 
noticed that the PCR yield for the 5th and 6th round of selection was much higher than the 
previous rounds probably due to the decrease in the guanine percentage. 
 
Table 3.1. NMM aptamer sequences after 3 and 6 rounds of selection* 
Clone                Sequence (5’ - 3’) 
 
3.1   AGCAGCACAGAGGTCAGATGGTAAAGAGATTCTAATGGGGGATGGTCCTGTAGTTCCCTCCCTATGCGTGCTACCGTGAA 
3.2   AGCAGCACAGAGGTCAGATGAAGGGGGGCGCCTTAGACTGGCCATAAATAGGGTAGTACTCCTATGCGTGCTACCGTGAA 
3.3   AGCAGCACAGAGGTCAGATGTTGAAAGTGGGGGTCACGGTGTGCATTGGGTAAACAGATGTCCTATGCGTGCTACCGTGAA 
3.4   AGCAGCACAGAGGTCAGATGTATTTCGGGGTTGATTAAACGCGAGTAAAGCACCACTGTTCCTATGCGTGCTACCGTGAA 
3.5   AGCAGCACAGAGGTCAGATGAAAAGAATGCTCATCCTGGGGTAGGCATGAAGCGGGGCCGCCTATGCGTGCTACCGTGAA 
3.6   AGCAGCACAGAGGTCAGATGATTCGATGTTTTAATCTTAGAATAATTTGCTATTAAGCTTCCTATGCGTGCTACCGTGAA 
3.7   AGCAGCACAGAGGTCAGATGTACGCGTTGGGTTAATATGTGGGTAGTGTGTGTAGTGGACCTATGCGTGCTACCGTGAA 
3.8   AGCAGCACAGAGGTCAGATGAGGTTATCTCATCGATTTGTCATGCATTAGAACTCGTTTCCCTATGCGTGCTACCGTGAA 
3.9   AGCAGCACAGAGGTCAGATGGCTGAGAGGCCTTAGTGGGTAGGACAGTAATGGGGGTGACCCTATGCGTGCTACCGTGAA 
3.10  AGCAGCACAGAGGTCAGATGGGGGGTCTGCTGCATGACGGTTGGAGGTATGACGTTCCTACCTATGCGTGCTACCGTGAA 
3.11  AGCAGCACAGAGGTCAGATGACCTTGAACACTCAGGTTCTTTTTCAGGGGGCCTAAACATCCTATGCGTGCTACCGTGAA 
3.12  AGCAGCACAGAGGTCAGATGATGGTCATTGGGGGACAAACTGGCTAGAGGGCTCGGGGTTCCTATGCGTGCTACCGTGAA 
3.13  AGCAGCACAGAGGTCAGATGAAGGGTTGAATATGGGAATTGGTAGAGGGGAACACAGCTGCCTATGCGTGCTACCGTGAA 
3.14  AGCAGCACAGAGGTCAGATGATTTGGGATGTCTGAAGGGGCGCCGAATTATAGTGCTTCCCCTATGCGTGCTACCGTGAA 
3.15  AGCAGCACAGAGGTCAGATGCGCTCTGTAGATAGCAACACATTGGAGGGGTGTAAAGATCCTATGCGTGCTACCGTGAA 
3.16  AGCAGCACAGAGGTCAGATGATTGGTGTTAGGGGCGATCCTGTCTGGGGGTAGTCGCTGCCTATGCGTGCTACCGTGAA 
3.17  AGCAGCACAGAGGTCAGATGGGGGGTTAATAGTGTCGCCTAAGGTCACCGCCGCGGGGTACCTATGCGTGCTACCGTGAA 
3.18  AGCAGCACAGAGGTCAGATGTTCAGCGATTACTCCAGGCCAACGGGGAACCAAAGGGGTCCTATGCGTGCTACCGTGAA 
3.19  AGCAGCACAGAGGTCAGATGTTGACACCGATGCGGTATCAGGGGGGCGAGTAGCGCCGCACCTATGCGTGCTACCGTGAA 
3.20  AGCAGCACAGAGGTCAGATGACTAGCGGGAGTGCTTCGGTCTGGATGCGCATGGGGTATGCCTATGCGTGCTACCGTGAA 
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 6.1   AGCAGCACAGAGGTCAGATGATTAATTTTTTTGTTTGATTATAATTTTAGTACTGATTCACCTATGCGTGCTACCGTGAA 
 6.2   AGCAGCACAGAGGTCAGATGATCTACGCTGTATTCGCAAACTATAATGCCCGGTAGTACCCCTATGCGTGCTACCGTGAA 
 6.3   AGCAGCACAGAGGTCAGATGGACTCAGTCAGCCTGTCAAATGTACGTTAGATTTTCAATGCCTATGCGTGCTACCGTGAA 
 6.4   AGCAGCACAGAGGTCAGATGATTGGAGGAAGGGAGGTACAGTTACATATCACGTTAACGGCCTATGCGTGCTACCGTGAA 
 6.5   AGCAGCACAGAGGTCAGATGGTCTTTTTTATCACTAGGTTAAATCCAATTCTTCGTTCTTCCTATGCGTGCTACCGTGAA 
 6.6   AGCAGCACAGAGGTCAGATGTAGATTATTAAGAAAGCATAGTTGGAGCTAAAATACGGTTCCTATGCGTGCTACCGTGAA 
 6.7   AGCAGCACAGAGGTCAGATGATCACATCTCCAGGTTTCTGGGAAGTAGCACCCTCAAACGCCTATGCGTGCTACCGTGAA 
 6.8   AGCAGCACAGAGGTCAGATGTTGACTCGTTAATCGTAATTTAAAAATCAGGTATCCTTCTCCTATGCGTGCTACCGTGAA 
 6.9   AGCAGCACAGAGGTCAGATGGCTAGTCCAGCTGTCAGGAGTGCACACCTCCCGTCAATAGCCTATGCGTGCTACCGTGAA 
 6.10  AGCAGCACAGAGGTCAGATGAAGCCTATCTTGGAGCTTTGCAGACTCGATGTATAGTACGCCTATGCGTGCTACCGTGAA 
 6.11  AGCAGCACAGAGGTCAGATGTTTATAGCAATCTCGATAGGGTAAAGATGTGGTGGGTTGCCCTATGCGTGCTACCGTGAA 
 6.12  AGCAGCACAGAGGTCAGATGTTATGAAATTAAAGACTTACCTTATAAGTTGTACAAACACCCTATGCGTGCTACCGTGAA 
 6.13  AGCAGCACAGAGGTCAGATGGGCGTAATAAATTCGTGGTAATAGAGGGTCTTTTGGCGCTCCTATGCGTGCTACCGTGAA 
 6.14  AGCAGCACAGAGGTCAGATGAGGCGCAGGTATACCAGGGCGGAGTAAAGTCCATGTAGGGCCTATGCGTGCTACCGTGAA 
 6.15  AGCAGCACAGAGGTCAGATGATTATGGTGTCCGATTATGGTGGGGGAATCACCCTATGCGTGCTACCGTGAA 
 6.17  AGCAGCACAGAGGTCAGATGTCGTAATCAGTGGGTGAGAACAGGCTAATCTACTAATCTGCCTATGCGTGCTACCGTGAA 
 6.18  AGCAGCACAGAGGTCAGATGAGTTTGCTCAATAAACGTTTTTACTGACTTGAATTCTGCCCCTATGCGTGCTACCGTGAA 
 6.19  AGCAGCACAGAGGTCAGATGATCAAGCGCAGAAACCTCCTATGCGGCCACGCAGTGCCCCCCTATGCGTGCTACCGTGAA 
 6.20  AGCAGCACAGAGGTCAGATGTTTAGAGTGGTTTTATGTATGGGTATTTTCATAGAAAGTGCCTATGCGTGCTACCGTGAA 
 6.21  AGCAGCACAGAGGTCAGATGGGTCTAATCATTGACTTACGTTGATGTGTCGATCTATGCTCCTATGCGTGCTACCGTGAA 
 6.22  AGCAGCACAGAGGTCAGATGTTATGAAATTAAAGACTTACCTTATAAGTTGTACAAACACCCTATGCGTGCTACCGTGAA 
 6.23  AGCAGCACAGAGGTCAGATGTGCTCGACTATTGAGTCAGGGGGTTGGGGCAACAATAAGCCCTATGCGTGCTACCGTGAA 
 6.24  AGCAGCACAGAGGTCAGATGGTTTAGTCTACGACATCGAATAAGTGTCTTTCAATTCACACCTATGCGTGCTACCGTGAA 
 6.25  AGCAGCACAGAGGTCAGATGTTGGGCCTACGGGGACACCAAACGGGGAGTCTAAATGCTACCTATGCGTGCTACCGTGAA 
 6.26  AGCAGCACAGAGGTCAGATGGTCACGTTATTTAACTTAGGAGAATAGAACACCCGCTGTTCCTATGCGTGCTACCGTGAA 
 6.27  AGCAGCACAGAGGTCAGATGTAGACGGTAACGCAACCTATATTAGGATTTTAGAGTTACCCCTATGCGTGCTACCGTGAA 
 6.28  AGCAGCACAGAGGTCAGATGGGTATACGTTATGATATTACTAAAAAGGGACAGTGTTCAGCCTATGCGTGCTACCGTGAA 
 6.29  AGCAGCACAGAGGTCAGATGCCCTTTTAAAGACTTTCACTAGGCCTTCTAACACAGTAAACCTATGCGTGCTACCGTGAA 
 6.30  AGCAGCACAGAGGTCAGATGTAACGGCGAGTGATTACGACTCTCACGGGTAGTCGGTCAACCTATGCGTGCTACCGTGAA 
 6.31  AGCAGCACAGAGGTCAGATGATATACGTCTATAAGTTCTGACTTTTGAAATAGAGTGAATCCTATGCGTGCTACCGTGAA 
 6.32  AGCAGCACAGAGGTCAGATGAATTCTGTTCCCTGATATTAATCTGCACCCCTCCTACACCCCTATGCGTGCTACCGTGAA 
 6.33  AGCAGCACAGAGGTCAGATGATAATTGCGTATAGTATGCTCTCTGCTGTTTGGTAATAAGCCTATGCGTGCTACCGTGAA 
 6.34  AGCAGCACAGAGGTCAGATGTTTAGAGTGGTTTTATGTATGGGTATTTTCATAGAAAGTGCCTATGCGTGCTACCGTGAA 
 6.35  AGCAGCACAGAGGTCAGATGATATGGTTTTATTTATTACATAGATTTTGCTAGGTATTTACCTATGCGTGCTACCGTGAA 
 6.36  AGCAGCACAGAGGTCAGATGATCAGTAGTAACTCTTCTATCCTACGCATAATGGTTCGGGCCTATGCGTGCTACCGTGAA 
 
* Bases in bold represent the primer regions. 
 
Dissociation constants of selected aptamers 
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Four sequences were randomly chosen from each of the sequenced pools for further 
characterization. Two sequences from 6th round pool that appeared twice in the cloning results 
were chosen since these sequences may be present in higher abundance. The dissociation 
constants for these sequences were determined by measuring the fluorescence enhancement of 
NMM upon binding DNA aptamers. Figure 3.5 shows a representative binding curve of one of 
the clones and a similar curve for the starting library. The fluorescence intensity of NMM-clone 
6.23 complex (red) reaches saturation in the presence of approximately 12.5 µM aptamer while 
even in the presence of 100 µM library, the fluorescence intensity of NMM is less than half of the 
maximum and it is still continuously increasing according to the trend (blue). Clearly there is a 
substantial improvement in the binding affinity for the selected clones. 
 
Figure 3.5. Binding curves for clone 6.23 (red open circles) and the random ssDNA library (blue 
solid circles). The error bar represents the standard deviation. The Kd determined for clone 6.23 is 
1.2 ± 0.1 µM. The Kd for the unselected library is estimated to be > 50 µM. 
  
The dissociation constants of all the synthesized clones are summarized in Table 3.2. All 
the clones from the 3rd round pool bind the NMM with Kd values ranging from hundreds of 
nanomolar to several micromolar. This is again in good accordance with previously reported Kd 
values for NMM aptamers36, 208, 209. It also demonstrates that DNA aptamers binding NMM can be 
evolved after only 3 rounds of CE-SELEX selection. However, for sequences from the 6th round, 
only clone 6.23 binds the NMM with a similar Kd of 1.2 µM. Clone 6.4 binds the NMM with a 
fairly high Kd of 43 µM and all the other clones are not fully bound even at the highest DNA 
concentration assessed (40 µM or 100 µM). This deterioration in the binding efficiency of the 
pool is probably driven by the PCR bias for sequences with lower guanine content. As the 
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selection goes on and the abundance of binding sequences gets higher, PCR efficiency may play a 
more important role, impacting the selection more than the CE separation. Another possibility is 
that the non-responsive clones from the 6th round pool may bind the NMM but could not be 
measured using the above method if binding did not induce an enhancement in fluorescence. 
Table 3.2. Dissociation Constants (Kd) of Sequences Chosen at Random from Table 3.1. 
Sequences      Kd (µM)* 
 
Clone 3.2     5.1 ± 0.9 
Clone 3.5   0.88 ± 0.12 
Clone 3.12     3.0 ± 0.5 
Clone 3.14     6.4 ± 0.6 
Clone 6.4      43 ± 32 
Clone 6.6         > 50 
Clone 6.8         > 50 
Clone 6.12 & 6.22        > 20 
Clone 6.20 & 6.34        > 20 
Clone 6.23     1.2 ± 0.1 
Library          > 50 
 
* Errors represent the standard error. 
 
Enzymatic activity 
NMM is a distorted porphyrin ring that has been used as a transition state analog for the 
porphyrin metallation reaction207. Previous studies have found that NMM binding aptamers are 
also capable of catalyzing the corresponding metal insertion reaction by stabilizing the transition 
state of the reaction36, 37, 208, 210. In order to test whether the DNA aptamers selected by CE-SELEX 
are also catalytic, we studied the insertion reaction of Cu (Ⅱ) into mesoporphyrin IX (MP). 
Figure 3.6a illustrates the overall reaction equation. The inserted Cu (Ⅱ) coordinates the four 
nitrogen atoms and results in a structure with a higher degree of symmetry. This changes the 
electronic structure and thus the UV-Vis spectra of the porphyrin. Figure 3.6b and 6c show the 
UV-Vis absorption spectra of the substrate MP and the product Cu-MP. Upon metallation, the 
intense B band around 400 nm narrows and the intensity increases slightly. The four Q bands 
from 500 to 700 nm collapse into two more intense bands (λ = 525 nm and 561 nm). The overall 
reaction rate was measured at 561 nm due to the higher signal to noise ratio. 
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Figure 3.6. (a) Insertion reaction of Cu (Ⅱ) into mesoporphyrin Ⅸ (MP); (b, c) UV-Vis spectra 
of MP (b) and Cu-MP (c). 
 
Figure 3.7 shows the increase of absorbance at 561 nm over the first 60 min of reaction. 
Clearly, the metalloporphyrin forms faster in the presence of clone 6.23 (red open circles) than in 
the absence of the DNA aptamers (blue solid circles). Among all the clones selected by CE-
SELEX, clone 3.5 and clone 6.23 were found to accelerate the reaction by 1.7 and 2.0 fold, 
respectively (Table 3.3). All other clones listed in Table 3.2 were found to be non-catalytic. 
Similarly, the random library does not catalyze the reaction. It was found that the two catalytic 
clones are also the two with the lowest dissociation constants (0.88 µM for clone 3.5 and 1.2 µM 
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for clone 6.23). This suggests that the catalytic activity depends strongly on how tightly the 
aptamers can bind the transition state. We have also measured the reaction rate in the presence of 
a 18mer aptamer (5’-GTG GGT TGG GTG GGT TGG-3’) that has previously been shown to 
bind NMM and accelerate the reaction for comparison215. The 18mer aptamer shows 7.1-fold rate 
enhancement under the same reaction conditions. The dissociation constant of the 18mer aptamer 
was measured to be 0.7 µM using the fluoresence method as described above. Apparently 
aptamers with Kd values of about 1 µM or even lower are required to catalyze this reaction. For 
all the other selected aptamers with Kd values significantly larger than 1.0 µM, we assume that 
the energy released upon binding the transition state is not sufficient to accelerate the reaction 
considering the low fraction of bound species under the reaction condition. 
 
Figure 3.7. Absorbance at 561 nm in the presence (red open circles) and absence (blue solid 
circles) of clone 6.23. 
 
Table 3.3. Catalytic Activity of Selected Aptamers 
Sequence    Vobs (µM/min)* 
 
Clone 3.5   0.0441 ± 0.0005 
Clone 6.23   0.0538 ± 0.0003 
background   0.0264 ± 0.0003 
library    0.0272 ± 0.0006 
18mer      0.187 ± 0.001 
 
* Errors represent the standard error. 
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3.4 Conclusions 
We have used CE-SELEX to successfully isolate DNA aptamers for a small molecule 
target NMM with high nM to low µM affinity in only three rounds of selection. Among the 
selected aptamers, the strongest binders also exhibit catalytic activity for the porphyrin 
metallation reaction. Conventionally, selection of aptamers for small molecule targets like NMM 
requires being attached to solid phase support and subjected to affinity column separation. 
Compared to the affinity chromatography method, CE-SELEX greatly reduces the selection time 
and the number of cycles needed (3 vs 10-12 rounds). It also eliminates the necessity of solid 
phase attachment, reducing the potential for non-specific interactions. The free solution 
environment for binding and separation allows the aptamers to access the target from all 
directions facilitating the discovery of binders using various approaches. More importantly, this 
study demonstrates the feasibility of applying CE-SELEX for small molecule targets which 
contain a class of important compounds for cell signaling and regulation. The characteristic of 
nucleic acids of being able to be amplified by PCR makes even partial separation adequate for 
CE-SELEX to be carried out. It broadens the scope of targets for CE-SELEX and also provides a 
new technique for selection of aptamers towards small molecule targets. Therefore, we believe 
CE-SELEX is a more versatile technique than previously perceived. 
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Chapter 4: Selection of DNA Aptamers against a Fully Intact Membrane Protein 
using Capillary Electrophoresis - SELEX 
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4.1 Introduction 
Aptamers have great applications in diagnostics and therapeutics due to their high 
binding affinity and specificity. They can be used for protein biomarker detection and 
quantification replacing antibodies. Aptamers have also been identified for a wide range of 
therapeutic targets and thus can be used as drugs. However, most current aptamers target 
extracellular proteins. Due to the high negative charge and large molecule size, it is difficult for 
aptamers to cross cellular membranes and target intracellular molecules. The same problem has 
also been encountered by many other macromolecular drugs, such as antibodies, siRNA and 
nanoparticles. In order to enhance the delivery of macromolecular drugs into cells for treating 
intracellular targets, an agent molecule that binds membrane receptors involved in receptor-
mediated endocytosis would facilitate transmembrane delivery. Therefore, aptamers selected for 
specific membrane receptors included in endocytosis could be used as delivery agents for 
macromolecules into cells. 
Selection of aptamers against intact membrane proteins is not an easy task for 
conventional SELEX which uses nitrocellulose filtration or affinity chromatography selections. 
This is because the lipids or detergents used to solubilize the transmembrane domains may disrupt 
the retention of complex on nitrocellulose filters and it is difficult to attach the whole membrane 
proteins onto a solid phase without denaturing. Previous selections were performed against 
synthetic peptide regions or truncated portions of the whole protein216, 217. However, the truncated 
portions may fold differently from the integral whole membrane protein preventing the selection 
of aptamers against the native conformations of the targets, and thus the selected aptamers may 
not even recognize the native proteins in vivo. CE-SELEX is a free-solution environment 
technology, fully compatible with membrane protein targets as various detergents or lipids are 
often used as buffer additives in capillary electrophoresis separations. Therefore, CE-SELEX is 
expected to be a promising approach for the selection of aptamers against fully intact membrane 
protein targets. 
In this Chapter, we describe the selection of aptamers against a fully intact membrane 
protein target - transferrin receptor (TfR) using CE-SELEX. TfR is a receptor involved in 
receptor-mediated endocytosis and is responsible for iron delivery into cells and is ubiquitous in 
mammalian cells. It is a homodimer of two transmembrane subunits linked by disulfide bonds. 
Each subunit contains a large C-terminal extracellular domain, a hydrophobic transmembrane 
domain and a small N-terminal cytoplasmic domain. Two atoms of Fe3+ bind the soluble 
glycoprotein transferrin to form transferrin-Fe3+ which then binds the C-terminal of the receptor 
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to form the multimeric iron complex. The whole complex is immediately internalized into cells 
upon binding TfR via receptor-mediated endocytosis through clathrin-coated pits. Fe3+ is further 
released from the complex in the low pH endosome (pH 5.5) due to the conformational changes 
of both transferrin and the receptor. The resulting apotransferrin-receptor complex is recycled to 
the cell surface and dissociated later in the neutral pH environment for further iron endocytosis. 
TfR is expressed on all dividing cells and is particularly enriched on precursors of the erythron as 
these cells have the highest ion demand 218. It has also been implicated in transcytosis across brain 
capillary endothelial cells, offering the potential for accessing targets across the blood-brain 
barrier 219, 220. Aptamers against the truncated extracellular domain of mouse TfR has been 
previously selected using conventional SELEX and found to be able to deliver conjugated 
proteins into cells through receptor-mediated endocytosis upon binding TfR 217. We now perform 
the selection against the fully intact TfR and expect the aptamers selected against the whole TfR 
will show higher affinity and more robust recognition for the native conformation of TfR on 
cellular membranes. Upon binding TfR, the aptamers can be potentially transported into cells via 
the receptor-mediated endocytosis process. Finally, the TfR used in this study is of human origin 
so that the aptamers selected can be later used to deliver macromolecular drugs for treating 
intracellular targets relevant to human disorders. 
 
4.2 Experimental Section 
Chemicals 
Full-length human transferrin receptor (TfR) containing all domains (extracellular, 
intracellular and transmembrane) was purchased from OriGene (Rockville, MD). 6-FAM labeled 
ssDNA library containing 40 central random bases flanked by 20 primer binding regions on either 
end (5’-AGC AGC ACA GAG GTC AGA TG (40 random bases) CCT ATG CGT GCT ACC 
GTG AA-3’) was purchased from IDT (Coralville, IA). 6-FAM labeled forward primer, biotin 
labeled reverse primer, unlabeled both primers and selected aptamers were also synthesized by 
IDT (Coralville, IA). dNTPs, 25 bp DNA ladder, αMEM, FBS, penicillin-streptomycin and 0.25% 
trypsin-EDTA were purchased from Life Technologies (Grand Island, NY). Taq polymerase and 
ThermoPol buffer were from New England Biolabs (Ipswich, CA). The gel loading dye was from 
Promega (Madison, WI). All other chemicals were purchased from Sigma-Aldrich (St. Louis, 
MO). All the samples and buffers were prepared using nuclease-free water (IDT, Coralville, IA). 
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The human pre-adipocyte cell line was kindly provided by Dr. David Bernlohr at the University 
of Minnesota (Minneapolis, MN) and Dr. James Kirkland from Mayo Clinic (Rochester, MN). 
CE-SELEX selection 
The TfR was reconstituted in 0.1% C12E8 micelles to solubilize the transmembrane 
domain and better mimic the native conformation of the protein as in cell membranes. The 6-
FAM labeled ssDNA library was first heated to 72 °C for 5 min and then cooled down to room 
temperature to let sequences fold into the favorable conformations. 500 nM of the above ssDNA 
library was then incubated with 10 nM of the target protein TfR in MOPS buffer (20 mM MOPS, 
5 mM KCl, 1 mM MgCl2 and 0.1% C12E8, pH 7.4) at room temperature for 30 min to achieve 
binding equilibrium. The separation capillary (40 cm long with 30 cm to the detector, 360 µm OD 
and 50 µm ID, Polymicro, Phoenix, AZ) was rinsed with 0.15 M NaOH at 30 psi for 4 min and 
then the buffer at 30 psi for 4 min. After that, the binding mixture was loaded onto the pre-
conditioned capillary at 5 psi for 32 seconds to fill 60% of the whole capillary using the P/ACE 
MDQ capillary electrophoresis system (Beckman Coulter, Fullerton, CA). The bound sequences 
were allowed to separate from the unbound sequence and migrate towards the capillary outlet vial 
containing 48 µL of separation buffer for collection by applying a normal polarity voltage at 30 
kV. Laser-induced fluorescence detection was applied to monitor the separation. 
The binding sequences collected were PCR amplified using 6-FAM labeled forward 
primer (5’/6-FAM/-AGC AGC ACA GAG GTC AGA TG-3’) and biotinylated reverse primer 
(5’/biotin/-TTC ACG GTA GCA CGC ATA GG-3’) for 30 cycles at the following condition: 200 
µM dNTPs, 510 nM of each primers, 0.025 unit/μL Taq polymerase and 7.5 mM MgCl2 in 1x 
ThermoPol buffer containing 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4 
and 0.1% Triton X-100, pH 8.8.  30 sec of denaturation at 94 °C, 30 sec of annealing at 53 °C and 
20 sec of extension at 72 °C were carried out for each cycle and followed by a final extension 
period of 5 min at 72 °C. Electrophoresis of the PCR products on 1.5% agarose gel stained with 
ethidium bromide was performed and the gel was imaged using a UV transluminator (Spectroline, 
Westbury, NY) to verify the absence of contamination bands and estimate the PCR yield. 
The PCR products were then made single stranded to recover the forward strand with the 
binding sequence information. The PCR products were first incubated with streptavidin agarose 
resin (Pierce Biotechnology, Rockford, IL) in binding buffer (10 mM Tris, 50 mM NaCl and 1 
mM EDTA, pH 7.5) in a chromatography column (Bio-Rad, Hercules, CA) for 30 min with 
periodical shaking. Then the resin was rinsed with 1 mL of binding buffer 10 times to wash off all 
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the PCR reagents but leaving the dsDNA products. After rinsing, the forward strand ssDNA was 
eluted from the column using 0.15 M NaOH. Then the sequences were desalted and precipitated 
by ethanol precipitation and dried in a CentriVap concentrator (LABCONCO, Kansas City, MO). 
The dried DNA was then dissolved in 30 μL of buffer, within which 10 μL was used for the next 
round of selection and the remainder could be used for binding characterization. 
Binding affinity measurement 
The binding affinity of each selected pool as well as the randomly chosen aptamer clones 
was measured using affinity capillary electrophoresis (ACE). Typically, 10 μL dilute of the 
selected ssDNA was heated to 72 °C for 5 min and cooled down to room temperature to fold into 
the correct structures and conformations. The DNA sample was then mixed with increasing 
concentrations of TfR samples ranging from 7.8 nM to 250 nM and incubated at room 
temperature for 30 min to allow binding to reach equilibrium. After that, the binding samples 
were injected onto a capillary and separated under 30 kV voltage of reverse polarity. The free 
unbound DNA peak was used to calculate the bound fraction fb: 
 𝑓𝑏 =  
[𝐴]𝑏
[𝐴]𝑡
 =  1 −
𝐼
𝐼0
=  
[𝑇]
[𝑇] +  𝐾𝑑
 4.1 
 
where I and I0 are the area or height of the free DNA peak in the presence and absence of 
target protein [T]. The bound fraction was then fitted to the target concentration to find Kd using 
origin 8.5 (OriginLab Corporation, Northampton, MA). 
The binding affinity of the selected pools was also estimated using fluorescence 
polarization. The fluorescence polarization as well as the fluorescence intensity of the binding 
samples at different DNA/protein molar ratios were measured using a Synergy 2 microplate 
reader (BioTek, Winooski, VT). It was excited using a 485/20 nm filter and the emission 
fluorescence was measured at 528/20 nm. The changes in the polarization of the binding mixtures 
relative to that of the free DNA sample was used to estimate the affinity: 
 𝑓𝑏 =  
𝑃 −  𝑃𝑓
𝑃𝑏 − 𝑃𝑓
=  
[𝑇]
[𝑇] +  𝐾𝑑
 4.2 
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where P, Pf and Pb are the polarization of the DNA at protein concentration [T], 
completely free ([T] = 0) and fully bound ([T] = ∞), respectively. Since (Pb - Pf) is constant, the 
relationship between (P - Pf) and [T] can be used to estimate the Kd. 
Cloning and sequencing 
When no further improvement in the binding affinity of the selected pools was observed, 
the iterative selection process was stopped and the selected pools were cloned and sequenced. 
Selected DNA sequences from round 2 and round 4 pools were cloned using a TOPO TA cloning 
kit (Invitrogen, Grand Island, NY). Briefly, the sequences from the two selected pools were PCR 
amplified using unlabeled primers under the same conditions as described above for only 20 
cycles and a final extension period of 10 min at 72 °C. The fresh PCR products were ligated onto 
the pCR4-TOPO vector, transfected into TOP10 Chemically Competent E.coli cells and then 
plated on LB agar plates. Individual colonies were randomly picked and cultured in LB broth 
(Invitrogen, Grand Island, NY) for 24 hours. The plasmids containing the PCR products were 
then extracted from E.coli cells using a plasmid miniprep kit from Invitrogen (Grand Island, NY). 
The vectors were sequenced at the BioMedical Genomics Center at the University of Minnesota 
(St. Paul, MN) using the M13 forward primer. 
Endocytosis of selected aptamers 
Human pre-adipocytes were cultured in αMEM with 10% FBS and 1% of 10000 U/mL 
penicillin-streptomycin (Invitrogen, Grand Island, NY) in a Nunc Lab-Tek 8-well chambered 
coverglass dish (Thermo Scientific, Waltham, MA) to 80% confluency. Cells were washed three 
times with PBS buffer and then incubated in serum-free αMEM with 10 μM of 6-FAM labeled 
aptamers at 37 °C with 5% CO2 for 30 min. The cells were then washed three times with PBS 
buffer to remove any non-internalized FAM-aptamers and fixed with 4% paraformaldehyde at 
room temperature for 15 min. The fixed cells were further washed with PBS buffer three times 
and kept in PBS buffer at 4 °C until imaging. An inverted confocal fluorescence microscope 
(Olympus FluoView FV1000 IX2, Imaging Center, University of Minnesota, Minneapolis, MN) 
equipped with pulsed 405 and 485 nm lasers was used to image the fixed cells. Images were 
captured and processed using FluoView (Olympus). 
 
4.3 Results and Discussions 
Capillary electrophoresis selection 
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The binding buffer containing C12E8 surfactant was used as the CE separation buffer to 
solubilize the transmembrane domain of the protein and maintain its active folding structure. In 
the presence of the surfactant, the capillary wall was coated and the EOF was largely suppressed. 
When applying normal polarity separation, the free unbound sequences migrated back towards 
the inlet buffer vial; while the target TfR was found to migrate towards the negative cathode at 
the capillary outlet. Considering the large size of the target protein, especially when incorporated 
into micelles, the binding complex was presumed to migrate towards the outlet as well. Therefore, 
the collection was done at the capillary outlet under normal polarity separation at 30 kV. This 
strategy minimizes the contamination from collecting tailing peak of the free DNA peak. 
The starting library was found to have only weak affinity for the target TfR (high nM to 
low µM). In order to minimize non-specific binding, the library concentration was kept low at 
500 nM. The TfR concentration was kept 50-fold lower (10 nM) to create competition for binding 
sequences. Meanwhile, in order to maximize the number of sequences for the selection, 60% of 
the entire capillary was loaded with the binding mixture as opposed to the narrow plug of sample 
typically injected in normal CE-SELEX selection. Since the binding sequences and the free DNA 
migrate in opposite directions, the amount of sample injected does not affect the resolution. 
Under a normal polarity separation, all the binding complex migrated towards the collection 
buffer vial for collection while the free DNA was removed via the inlet (see Figure 4.1). 
 
Figure 4.1. Illustration of the TfR selection scheme 
 
Binding affinity of selected pools. 
The binding affinity of the selected pools were studied using ACE to determine if further 
rounds of selection were needed. Figure 4.2 shows the electropherograms of the ACE analysis for 
the pool after three rounds of selection. As TfR increases, the intensity of the unbound DNA peak 
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decreases, indicating an increase in the bound fraction with increasing protein concentration. The 
bound fraction of the selected sequences was then fit to the equation to estimate affinity. 
 
Figure 4.2. Electropherograms showing the free unbound DNA peaks in the presence of 
increasing concentrations of TfR for ACE measurement for selection round 3 pool. 
 
The Kd of the selected pools as well as the starting library has been summarized in Figure 
4.3. After two rounds of CE-SELEX selection, the Kd has decreased drastically from high nM to a 
few tens of nM. However, there is no further improvement in binding affinity for the 3rd and 4th 
round. 
 
Figure 4.3. Dissociation constant Kd of starting library and selected pools measured using ACE 
peak area and height. The binding curve for peak area for the library did not converge. Error bars 
represent the standard deviation. 
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Figure 4.4a shows fluorescence polarization measurements for the selected pools and the 
starting library. At the same TfR concentration, the polarization values of the selected sequences 
are higher than the library, indicating a higher bound fraction at the same protein concentration 
and thus higher binding affinity. Excluding the data points at 250 nM TfR, the data shows trends 
typical of binding curves. The drop in fluorescence polarization at the highest protein 
concentration can be explained by the fluorescence enhancement effect with increasing protein 
concentrations. As shown in Figure 4.4b, the fluorescence intensity increases linearly with 
increasing protein concentration. The curves for the selected pools are randomly distributed. This 
fluorescence enhancement effect doesn't seem to have any trend in terms of selection rounds. So 
the fluorescence enhancement is probably due to a matrix effect (pH, glycerol level) in the protein 
sample rather than binding. Fluorescence enhancement is usually caused by an increase in the 
quantum yield and increase in fluorescence lifetime. According to the following equation, an 
increase in the fluorescence lifetime (τ) would result in a lower measured polarization value than 
in absence of that effect: 
 
1
𝑃
−  
1
3
= (
1
𝑃0
 −  
1
3
) (1 +  
𝑅𝑇
𝜂𝑉
𝜏) 4.3 
 
At the early stage of the binding curves, the increase in fluorescence polarization due to 
binding overcomes the decrease caused by longer fluorescence lifetime. Therefore, the overall 
effect on the measured polarization is still increasing, resembling the binding curves. However, 
when the protein concentration continues to increase, the binding curves start to reach a plateau 
and the decrease in polarization due to the longer fluorescence lifetime becomes dominant 
leading to a drop in the measured polarization values.  
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Figure 4.4. Change in fluorescence polarization (a) and fluorescence intensity (b) with increasing 
concentrations of TfR for library and selected pools. 
 
Given the limitation of top TfR concentration, it would be difficult to obtain a 
quantitative measurement for Kd from the fluorescence polarization data. However, from the early 
trend at lower protein concentrations, the polarization data still provides evidence supporting an 
increased bound fraction of DNA and increased affinity for TfR after CE-SELEX selections. 
Sequencing the selected pools 
Cloning and sequencing was performed for the selection round 2 and 4 pools. The 
sequences of aptamer clones randomly picked from the two pools are listed in Table 4.1. 24 
sequences were identified for each round. No sequence motif was identified and the sequence 
heterogeneity was high throughout the selection which are in agreement with previous CE-
SELEX studies. It also indicates that there are quite a few sequences in the library that could bind 
TfR. 
 
Table 4.1 TfR aptamer sequences identified from round 2 and round 4 pools*. 
 Clone                Sequence (5’ - 3’) 
 2_1:   AGCAGCACAGAGGTCAGATGACAAGGGAGATAGTCTTGCTATTTGATATTTACTTTGCACCTATGCGTGCTACCGTGAA 
 2_2:   AGCAGCACAGAGGTCAGATGGTACGGTATACTGTTTCTTATTTTTAGGTTAGATCTGGACCCTATGCGTGCTACCGTGAA 
 2_3:   AGCAGCACAGAGGTCAGATGGCAGGTTTCGACGTACAATGCTATGGAGACTTTATGATCGCCTATGCGTGCTACCGTGAA 
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 2_4:   AGCAGCACAGAGGTCAGATGCATTTATGTATCCTCTGTGAATGGCAGTTTATTGGACTAACCTATGCGTGCTACCGTGAA 
 2_5:   AGCAGCACAGAGGTCAGATGGTCTGTAGTGCTAATATTTAATTTAGTTATGTAACTGTTTCCTATGCGTGCTACCGTGAA 
 2_6:   AGCAGCACAGAGGTCAGATGGTCTCTGATACGATTATCGATCTAATTCCGATCGTAAGCTCCTATGCGTGCTACCGTGAA 
 2_7:   AGCAGCACAGAGGTCAGATGTAAAGTAAGTGTCGAATTCAATTTATGATTGTAGTTATGCCCTATGCGTGCTACCGTGAA 
 2_8:   AGCAGCACAGAGGTCAGATGCCAGGGGTATGACAATCGGTAGTTTGGAATGTATTCTAACCCTATGCGTGCTACCGTGAA 
 2_9:   AGCAGCACAGAGGTCAGATGAGTTTTTGTTGGGTTGTCTTGGATTTGTTGATTTAGTATGCCTATGCGTGCTACCGTGAA 
 2_10:  AGCAGCACAGAGGTCAGATGTGTGTTTATAGAAATGGTTTGACTTTGGTTAAGTAAATTACCTATGCGTGCTACCGTGAA 
 2_12:  AGCAGCACAGAGGTCAGATGAAGTTGTATTTGGTTATATGGCCTCGTGCTACTCGTTATTCCTATGCGTGCTACCGTGAA 
 2_13:  AGCAGCACAGAGGTCAGATGTACGCCATTCAGACATGGGCTTGGCAGCTGCAGAACTTTCCCTATGCGTGCTACCGTGAA 
 2_14:  AGCAGCACAGAGGTCAGATGCTTATAATAAGTTGATCTTATGCGGACAGGTCGCCCTCGTCCTATGCGTGCTACCGTGAA 
 2_15:  AGCAGCACAGAGGTCAGATGACTGTTATTTAGTTTTTCATCCTTGTTTTGCCCTTGTAATCCTATGCGTGCTACCGTGAA 
 2_16:  AGCAGCACAGAGGTCAGATGAGCCTTGCCATGTTGATTTAGAATTTAGCAGTATCCTTCTCCTATGCGTGCTACCGTGAA 
 2_17:  AGCAGCACAGAGGTCAGATGTCCTCTTTTCTTGTTAGCTACTGTACCTTATAGAATCTAACCTATGCGTGCTACCGTGAA 
 2_18:  AGCAGCACAGAGGTCAGATGTTGGTACGAGGCTGTGTTCTTATTAGTGGTGACTTTCCTACCTATGCGTGCTACCGTGAA 
 2_19:  AGCAGCACAGAGGTCAGATGCTTTGTCTTCATTCATTCATACTCCTGTCTGAACGGCTACCCTATGCGTGCTACCGTGAA 
 2_20:  AGCAGCACAGAGGTCAGATGTGACAGTTTTTAGTTACTGAACGATCTCAGCTAACATATCCTATGCGTGCTACCGTGAA 
 2_21:  AGCAGCACAGAGGTCAGATGTATGGTCATCACCACCCACGTTCGTGTGAAGAGTTGTGTTCCTATGCGTGCTACCGTGAA 
 2_22:  AGCAGCACAGAGGTCAGATGAGTTTTTGTTGGGTTGTCTTGGATTTGTTGATTTAGTATGCCTATGCGTGCTACCGTGAA 
 2_23:  AGCAGCACAGAGGTCAGATGTGACAGTTTTTAGTTACTGAACGATCTCAGCTAACATATCCTATGCGTGCTACCGTGAA 
 
 4_1:   AGCAGCACAGAGGTCAGATGTCCTGAAATATATAAGTAGTTTTGCTCTGCATCTCTCCGGCCTATGCGTGCTACCGTGAA 
 4_2:   AGCAGCACAGAGGTCAGATGGTATGTTCCTATGCGTGCTACCGTGAA 
 4_4:   AGCAGCACAGAGGTCAGATGGTTTGTTGTTCCGAATTCTGGTGTTGGTTCTTCTCGGATCCTATGCGTGCTACCGTGAA 
 4_5:   AGCAGCACAGAGGTCAGATGCCGAAGGTTCCTGTACAGTTGCAATCTATTTTAAGTTAGGCCTATGCGTGCTACCGTGAA 
 4_6:   AGCAGCACAGAGGTCAGATGTGGTAGTTAGTAGGCTTGAGGAACTTGTAGCTCAAACGCGCCTATGCGTGCTACCGTGAA 
 4_7:   AGCAGCACAGAGGTCAGATGACATTGTATCAGATCTCGCCGATCTTCTTGGTATCTGGAACCTATGCGTGCTACCGTGAA 
 4_8:   AGCAGCACAGAGGTCAGATGTTACTCTTTTTTTGGCTGTGACTTTCTATTCTGTTTGGTTCCTATGCGTGCTACCGTGAA 
 4_9:   AGCAGCACAGAGGTCAGATGTAATTGGGCGGGCCATCCTGTGTGGGGGGGTGCGTTTGTGCCTATGCGTGCTACCGTGAA 
 4_10:  AGCAGCACAGAGGTCAGATGTTGTATTTCGAATTTAAGCTCGTTGTACGGTCTATTTGGTCCTATGCGTGCTACCGTGAA 
 4_12:  AGCAGCACAGAGGTCAGATGTATTTGTTGTCTAGCGGGGATAGTGGTCAGTAAATCGTCACCTATGCGTGCTACCGTGAA 
 4_13:  AGCAGCACAGAGGTCAGATGTATTGTGTCCATAAACTTATCTGAGGATTGTTCCTACAGTCCTATGCGTGCTACCGTGAA 
 4_14:  AGCAGCACAGAGGTCAGATGTGCATAAGATGGTTCGGATTTCCTACTTTTTACCGAGGAACCCATGCGTGCTACCGTGAA 
 4_15:  AGCAGCACAGAGGTCAGATGCCATCTATATTAGTGGGTAGTGAATACTTGTCTGGGGTTCCTATGCGTGCTACCGTGAA 
 4_16:  AGCAGCACAGAGGTCAGATGTTTCTGTTCGGTGGATTACTTCTCACTGGATTGACTATTCCTATGCGTGCTACCGTGAA 
 4_17:  AGCAGCACAGAGGTCAGATGTTAAAAAACTAGGGTTTTCATCACAGGTGTGGTGAATTAACCTATGCGTGCTACCGTGAA 
 4_18:  AGCAGCACAGAGGTCAGATGATAATTCTGGTGGTCGTGGAGGCTGAGAGTCTTATGGCAACCTATGCGTGCTACCGTGAA 
 4_19:  AGCAGCACAGAGGTCAGATGCTGTAGTTCTATTTCCGTCGATATGATCGAGTACAGGTTTCCTATGCGTGCTACCGTGAA 
 4_20:  AGCAGCACAGAGGTCAGATGTCACTCGGGTAGGTGTTATGGAGCGATCAGTGTTCTCGGTCCTATGCGTGCTACCGTGAA 
 4_21:  AGCAGCACAGAGGTCAGATGCATGGGTGTGGGGGCCAGGGGTGCGAAGTTGTGTGAGTTCCCTATGCGTGCTACCGTGAA 
 4_22:  AGCAGCACAGAGGTCAGATGGGCCCTGTTGATTCTTTCTCCTGGCGTCGTTTGTGCAGCTCCTATGCGTGCTACCGTGAA 
 4_23:  AGCAGCACAGAGGTCAGATGTTCCAAATGCGGGGATTGTTTAGATTAGTTAGTGTTTGTCCCTATGCGTGCTACCGTGAA 
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 4_24:  AGCAGCACAGAGGTCAGATGTAGTGTTACCTGAATGATAATAAGTAAGCGGTGTTCAGATCCTATGCGTGCTACCGTGAA 
 
* Bases in bold represent the primer regions. 
 
Binding affinity of selected aptamers 
Four sequences were randomly chosen from each of the sequenced pools for further Kd 
characterization using ACE. Figure 4.5 shows typical binding curves for the selected aptamers. 
The curves plateau at approximately 50 - 60% bound fraction, indicating only a fraction of the 
aptamers could fold into a binding conformation with affinity for TfR. 
 
Figure 4.5. Binding curves of selected aptamer Clone 2_22 fitted by ACE peak area (a) and 
height (b). Error bars represent the standard deviation. 
 
The dissociation constants Kd of all the aptamers chosen at random from Table 4.1 
measured by ACE and fitted by peak area and height are summarized Table 4.2. All the 
sequences bind TfR with low nM Kd values, which is in good agreement with the bulk Kd 
measured for the selected pools (see Figure 4.3). 
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Table 4.2. Dissociation constants (Kd) of selected TfR aptamers 
 Clone  ACE area Kd (nM)* ACE height Kd (nM)* 
 
  2_8           37 ± 9             44 ± 7 
  2_10           50 ± 10             59 ± 5 
  2_12           38 ± 5           100 ± 10 
  2_22           28 ± 5             34 ± 6 
  4_6           48 ± 7             90 ± 30 
  4_12         130 ± 30           100 ± 30 
  4_17           70 ± 20             60 ± 20 
  4_20           24 ± 4             41 ± 4 
  Library**             N/A         1500 ± 2000 
 
* Errors represent the standard deviation 
** Library Kd fitted by peak area does not converge 
 
Endocytosis of TfR aptamers 
The selected aptamers were synthesized with 6-FAM label at the 5’ position to facilitate 
both binding measurements and the microscopy imaging for endocytosis assessment. Since the 
TfR used in the selection is of human origin, a human cell line was used for the endocytosis. A 
human pre-adipocyte cell line was chosen. It was assumed that the aptamers could bind TfR on 
cell membrane and be internalized into the cells similarly to diferric transferrin. As shown in 
Figure 4.6 a, the cells themselves exhibit minimal green autofluorescence background. Upon 
treating with selected aptamers for 30 min, green fluorescence starts to develop both inside and 
outside the cells (Figure 4.6 c & d). The DNA aptamers seem to stick to the surface of the 
coverglass causing fluorescence outside of the cells. In order to combat that, the glass surface 
needs to be coated and passivated to minimize non-specific binding. Moreover, in order to 
determine whether the fluorescence inside the cells is internalized FAM-aptamers or non-specific 
binding of the aptamers to the bottom of the glass surface or the membrane surface, a z-stack scan 
along the depth or thickness of the cells is needed. Random sequence DNA library also gave rise 
to green fluorescence inside the cells (Figure 4.6 b). Considering the relative high affinity for the 
starting library, the DNA concentration (10 µM) used for treating the cells might be high enough 
to bind TfR and be internalized. Another possible explanation is that the synthesized aptamers 
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contain some free dyes and the observed fluorescence is the internalized free dye instead of the 
large aptamer complex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Endocytosis of TfR aptamers by cultured human pre-adipocytes. The aptamers are 
labeled with FAM (show in green) and the cells are imaged using confocal microscopy after 30 
min incubation at 37°C with (a) PBS buffer; (b) 10 µM FAM-library; (c) 10 µM FAM-clone 2_8; 
(d) 10 µM FAM-clone 4_6. Both transmitted light and green fluorescence channels are shown in 
the images. 
 
Therefore in order to clarify the endocytosis of the TfR aptamers, further experiments such as 
using a different human cell line that has better adherent property, or surface coating for the 
coverglass, or using HPLC purification to remove any free dye in the aptamers are needed. 
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4.4 Conclusions 
In this study, DNA aptamers with nM Kd have been selected against a fully intact 
membrane protein TfR using CE-SELEX. As opposed to conventional SELEX using only the 
extracellular domain of the membrane protein target, full-length protein has been reconstituted in 
micelles and used in this CE-SELEX study to mimic its native conformation as it is in cellular 
membranes. This prevents the selection against a misfolded or changed conformation of truncated 
extracellular domain of the whole membrane protein and is expected to provide better recognition 
against the native protein in cellular membranes. In order to confirm and obtain more accurate 
quantification of binding affinity of the selected aptamers, an orthogonal technique other than 
affinity CE needs to be applied for Kd measurement, such as isothermal titration calorimetry 
(ITC). 
It remains unclear whether the TfR aptamers can be endocytosed into cells upon binding 
the receptors. More experiments under different conditions need to be performed to achieve a 
conclusive answer. If the aptamers can transport across the cell membranes, further cellular 
pathways inside the cells, such as the eventual destination of the aptamer-TfR complex, 
dissociation of the complex, time course of the distribution of the internalized aptamers and the 
recylcling pathway of dissociated TfR, need to be assessed to fully understand the mechanisms 
and help the design of such delivery agents. To further test the ability of the aptamers as delivery 
agents, macromolecule cargoes can be conjugated onto the aptamers and the resulting cell 
function can be monitored to determine the delivery efficacy. 
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Chapter 5: Characterization of DNA/RNA Analogs’ Affinity against Cardiac 
Muscle Proteins 
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5.1 Introduction 
The heart beat is regulated by the Ca2+ concentration in cardiomyocytes with 
concentration reaching 1-10 µM for the systolic phase and 0.1 µM for the diastolic phase. 
Sarcoplasmic Reticulum (SR) and extracellular space are two calcium sources for Ca2+ cycling 
with Ca2+ concentration at 500 µM and 2-3 mM, respectively. Cardiac contraction is then 
triggered by elevated Ca2+ released from the lumen of the SR or extracellular space into the 
cytosol of cardiac cells. Later the Ca2+ is removed from the cytosol into the lumen by the Ca2+ 
pump Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) and the extracellular space by 
plasma-membrane Ca2+-ATPases (PMCAs) and Na+/Ca2+ exchangers (NCXs), in which SERCA 
accounts for over 70% of the Ca2+ removal 221. Therefore, SERCA determines the muscle 
relaxation rate and size of stored Ca2+ in the lumen which consequently affects the contractility in 
the subsequent beat. 
Phospholamban (PLN) is a small and reversibly phosphorylated transmembrane protein 
located in the cardiac sarcoplasmic reticulum (SR). When it is unphosphorylated, PLN binds to 
the SERCA and inhibits the activity of this Ca2+ pump. Adrenaline and other β-agonists released 
by the nervous system can bind the cell membrane β-adrenaline receptors and activate a signal 
cascade to generate cyclic AMP by adenylate cyclase. Elevated cAMP concentration activates the 
cAMP dependent protein kinase A (PKA) which in turn phosphorylates PLN. Once 
phosphorylated, the inhibition effect of PLN on SERCA is relieved. This phosphorylation can be 
then be reversed by a protein phosphatase (PP1). 
Ca2+ activates the muscle contraction by binding to the troponin in the thin filament. 
Troponin complex is a heterotrimer consisting of troponin C (TnC), troponin T (TnT) and 
troponin I (TnI). TnC is a Ca2+ binding subunit; TnT is used to anchor the complex to 
tropomyosin and TnI is an inhibition subunit that binds actin and blocks its binding site for 
myosin. When Ca2+ binds the TnC, it results in a conformational change to remove the steric 
block and allow the actin in the thin filament to bind myosin in the thick filament for muscle 
contraction 222. Upon removal of the Ca2+ or lowering of the concentration, Ca2+ dissociates from 
TnC and the TnI blocks the actin-myosin interaction again for relaxation. Like PLN, myofibrillar 
proteins such as troponin I and C proteins can also be phosphorylated by PKA, which regulates 
the tension-generating ability at a given submaximal [Ca2+] and the myofilament Ca2+ sensitivity 
223, 224. 
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As discussed above, these contractile proteins or Ca2+ channels in cardiomyocytes are 
important in regulating the Ca2+ level and maintaining heart function. Dysfunction of Ca2+ cycling 
in cardiac myocytes is relevant in the development of heart failure. For example, super-inhibition 
or loss of inhibition effect of PLN on SERCA activities can cause the development of dilated 
cardiomyopathies 225, 226. ssDNA was found to bind PLN with high affinity and reverse its 
inhibition effect on SERCA. It acts in a tunable and length dependent way with 80mer completely 
relieving the inhibition effect and 5mer with almost no effect. Therefore, ssDNA can be 
potentially used for treating heart diseases caused by super-inhibition of PLN on SERCA. 
However, ssDNA is not stable in vivo and can be quickly degraded by DNases. Better drug 
candidates would be molecules with similar binding affinity for PLN but have higher biostability. 
Various nucleic acid analogs that are modified against enzymatic degradation are suitable for this 
task. Moreover, the effect of these analogs on other contractile proteins need to be evaluated and 
the mechanism of the high affinity binding needs to be investigated. In this Chapter, the binding 
affinity of DNA/RNA analogs with several important cardiac muscle proteins have been studied 
and more experiments are needed to elucidate the DNA/protein interaction profiles in cardiac 
myocytes. 
 
5.2 Experimental Section 
Chemicals 
5mer, 10mer, 20mer, 35mer and 50mer random RNA libraries and 50mer 2’-O-methyl 
modified random RNA were purchased from IDT (Coralville, IA). 50mer random sequences of 
L-DNA was purchased from ChemGenes (Wilmington, MA). All the above sequences are labeled 
by 6-FAM for fluorescence detection. Phospholamban (PLN) reconstituted in 0.1% C12E8 was 
kindly given by Professor Veglia lab. Troponin complex, its subunit C, T and I, and Myosin S1 
subunit were kindly provided by Professor Metzger lab. All the other chemicals for buffers are 
obtained from Sigma-Aldrich (St. Louis, MO) and the buffers are all prepared using nuclease-free 
water from IDT (Coralville, IA). 
Binding affinity measurement 
The dissociation constants of various DNA/RNA analogs binding different cardiac 
muscle proteins are measured using both affinity capillary electrophoresis (ACE) and 
fluorescence polarization (FP) methods. The concentration of the DNA/RNA analog was kept 
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constant and titrated with increasing concentration of proteins. Typically, 5 nM of the DNA/RNA 
analog was heated to 72 °C and cooled down to room temperature to allow sequences to fold into 
the most stable conformations. They were then mixed with proteins of concentrations ranging 
from low nM to µM and incubated at room temperature for 30 min to reach binding equilibrium 
before measurement. 
For ACE measurement, equilibrium mixtures at different binding ratios are separated in a 
40 cm long (with 30 cm to detector), 360 µm OD and 50 µm ID fused silica capillary (Polymicro, 
Phoenix, AZ) on P/ACE MDQ capillary electrophoresis system (Beckman Coulter, Fullerton, 
CA). The free unbound DNA/RNA peak was used to calculate the bound fraction and fitted to the 
binding curve to obtain Kd values: 
 𝑓𝑏 =  
[𝐴]𝑏
[𝐴]𝑡
 =  1 −
𝐼
𝐼0
=  
[𝑇]
[𝑇] +  𝐾𝑑
 5.1 
 
where I and I0 are the area or height of the free DNA peak in the presence and absence of 
target protein [T]. 
For FP measurement, the polarization of the binding samples are measured using a 
Synergy 2 microplate reader (BioTek, Winooski, VT). The excitation light at 485/20 nm was 
polarized and emission fluorescence was measured at 528/20 nm. The bound fraction of 
DNA/RNA analogs was determined by the following equations: 
 𝑓𝑏 =  
𝑃 −  𝑃𝑓
𝑃𝑏 − 𝑃𝑓
=  
[𝑇]
[𝑇] +  𝐾𝑑
 5.2 
 
where the difference of polarization of sequences at fully bound and completely unbound 
(Pb - Pf) is treated as a constant. Then the increase in polarization (P - Pf) can be fitted with 
respect to the target protein concentration [T] to obtain Kd. 
 
5.3 Results and Discussions 
Binding affinity of DNA/RNA analogs for PLN 
All the DNA/RNA analogs showed binding affinity in low nM range except for the 
shortest RNA 5mer (Figure 5.1). The 2’-O-methyl modification and the chirality does not affect 
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the binding affinity either. Since all the sequences are completely random, it reveals that the 
binding is independent of sequence and is probably through pure electrostatic interaction between 
the highly negatively charged nucleic acids and the relatively high PI protein PLN. The difference 
between the Kd measured by ACE and FP is due to the fact that FP measures equilibrium mixture 
while ACE requires high voltage separation and is also under nonequilibrium conditions. The 
equilibrium mixture may dissociate under high electric field and in the nonequilibrium buffers. 
This phenomenon is especially significant when the binding is weak or the dissociation rate of the 
complex is high, such as in the case of 5mer RNA. For the natural RNA sequences of different 
lengths, the binding affinity decrease as the length decreases, with the drastic drop in binding 
affinity for sequences less than 10 bases long. The length dependent binding property reveals that 
the binding site has a certain amount of positive charges that need to be saturated with enough 
long sequences to achieve high affinity binding or a certain amount of flexibility is needed. 
 
Figure 5.1. Dissociation constants (Kd) of the DNA/RNA analogs measured by ACE peak area, 
height and FP. The numbers above the columns are the corresponding Kd values in nM. Error bars 
represent the standard deviation. 
 
Binding affinity of ssDNA for troponin complex and its subunits 
Figure 5.2 shows the separation electropherograms for 80mer ssDNA and troponin 
complex (Tn3). As the concentration of troponin complex increases, the free unbound ssDNA 
peak decreases rapidly. The ssDNA shows high binding affinity (13 nM) against the troponin 
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complex, which is in the similar range as the PLN. It shows that there might be multiple protein 
targets in cardiac myocytes that can interact with ssDNA.  
 
Figure 5.2. Stacked electropherograms showing the change of the free unbound ssDNA peaks in 
response to increasing concentrations of troponin complex. 
 
Different troponin subunits show different binding affinity for the 80mer ssDNA (Figure 
5.3). The subunit I (TnI) binds the 80mer ssDNA with a lower affinity of a few hundred nM Kd. 
The subunit T (TnT) shows even higher Kd values. The subunit C (TnC) does not show any 
binding affinity towards ssDNA (> 12.5 µM). This suggests that the formation or the proper 
folding of troponin complex is required for high affinity binding (low nM Kd) with ssDNA given 
that the subunits themselves are not very much structured. 
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Figure 5.3. Dissociation constants (Kd) of 80mer ssDNA binding different subunits of troponin 
fitted by ACE peak area, height and FP data. The numbers above the column indicates the actual 
Kd values in nM. Error bars represent the standard deviation. 
 
Binding affinity of ssDNA for myosin S1 
Considering the fact that ssDNA binds the contractile protein troponin, we further studied 
if there are other proteins that are in high abundance in cardiomyocytes that could also bind the 
ssDNA. Myosin is a high abundant protein (40-50% of total muscle protein) consisting of two 
heavy chains and four light chains. The two heavy chains are wound around each other to form 
the backbone of the thick filament and at one end they form two globular heads with the light 
chains that are responsible for cross-bridging with the thin filament. The S1 fragment of myosin 
is a proteolytic portion from the heavy chain. It is water-soluble and can hydrolyze ATP and bind 
actin to form actomyosin complex, which is essential for the muscle to produce forces 227. In our 
experiment, myosin S1 fragment was found to bind ssDNA as well but to a lesser extent. As 
shown in Figure 5.4, the 80mer ssDNA also binds the soluble myosin S1 subfragment with a few 
hundred of nM Kd, which indicates a lower affinity than the PLN and troponin complex. 
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Figure 5.4. Binding curves fitted by (a) ACE peak height and (b) FP for 80mer ssDNA binding 
myosin S1 subunit. The Kd obtained are 524 ± 106 nM for ACE and 828 ± 154 nM for the FP 
respectively. The error bars represent the standard deviation. 
 
5.4 Conclusions 
In conclusion, PLN binds ssDNA, L-DNA, RNA and O-methyl RNA with low nM 
dissociation constants for sequences at least 10 nucleotides long. If the sequence is even shorter 
(e.g. 5 nt), the affinity drops drastically. This binding affinity is also independent of sequence, 
which implies a pure electrostatic binding mechanism. To further test this hypothesis, DNA/RNA 
analogs with non-charged backbone, such as Peptide Nucleic Acid (PNA) or less charged 
backbone such as phosphorothioate nucleic acids are needed to investigate the binding 
mechanism. ssDNA is not the naturally occurring format in vivo, however, single strand RNA is 
abundant in cells, such as miRNA and mRNA. Since RNA binds PLN equally well as or even 
tighter than ssDNA of the same length, it might play an important role in regulating heart 
functions. This is further supported by the fact that not only PLN binds with high affinity but also 
many other contractile proteins such as troponin and myosin bind. And it would be significant if 
nucleic acids can directly regulate protein activities. Last but not least, more studies need to be 
done before we can apply DNA/RNA analogs as treatment for PLN related heart failures.  
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Chapter 6: Conclusions and Future Directions 
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6.1 Summary of Research 
In summary, this dissertation is focused on the attempt to detect nucleic acid catalyst 
using a self-fabricated microfluidic device and CE-SELEX selection against difficult target 
molecules. In Chapter 2, we have demonstrated the use of a PDMS microwell array device for the 
detection of single enzyme molecules. The number of single enzyme molecules in the microwells 
followed Poisson distribution and different enzyme molecules showed heterogeneous activities 
over a wide range. The same strategy were then applied for the detection of catalytic sequences in 
a random nucleic acid library and allowed for the detection of sequences catalyzing separate 
substrates with multiple turnovers. However, initial effort on nucleic acid library failed to detect 
any catalytic sequences, indicating a lower abundance or lower activity should be expected. 
Chapter 3 described the application of CE-SELEX against a small molecule target - 
NMM. Aptamers have been selected after only three rounds of CE-SELEX selection. Two out of 
eight randomly chosen aptamers also showed catalytic activity for the corresponding metal 
insertion reaction of mesoporphyrin. This study has greatly lowered the low size limitation for 
CE-SELEX. 
Chapter 4 described the CE-SELEX selection against an intact membrane protein target - 
TfR. Aptamers have been isolated for full-length recombinant TfR after four rounds of selection, 
indicating that CE-SELEX is a preferred method than conventional SELEX as it allows the use of 
various membrane models to solubilize the transmembrane domains. Since TfR has important 
implication in receptor-mediated endocytosis, aptamers against TfR can be potentially engineered 
to deliver cargoes across membrane to intracellular spaces. Preliminary experiments were 
designed to study the endocytosis of aptamers upon binding TfR using confocal fluorescence 
microscope. Further studies are necessary to understand the efficacy of aptamer facilitated 
transmembrane delivery. 
Capillary electrophoresis also serves as an important analytical tool for binding affinity 
measurement. Chapter 5 discussed binding measurement for various DNA/RNA analogs with 
important cardiac muscle proteins using ACE and FP. All the analogs tested had high binding 
affinity for PLN, showing the potential as therapeutics for treating PLN-superinhibition related 
cardiomyopathy. These oligos also exhibited high affinity against contractile protein - trophonin 
and modest affinity for myosin, indicating possibly more sophisticated roles in regulating protein 
functions in cardiac myocytes. 
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6.2 Future Directions 
Researches on aptamers and nucleic acid catalysts have gained great success and are 
continuing to advance. One essential research area is the development of more efficient selection 
strategies for both aptamers and nucleic acid catalysts. It allows more convenient and effective 
discovery of valuable aptamer tools. On the more application side that is also prospering, 
aptamers can be selected against targets involved in more complicated systems with the promise 
of becoming regulation or therapeutic tools for more sophisticated functions. 
 
6.2.1 µFFE-SELEX vs CE-SELEX 
Although successfully solving difficulties in conventional SELEX, CE-SELEX still 
suffers from a few aspects. The small sample consumption is an advantage for CE when it comes 
to analytical purpose, however, it can be a limitation for SELEX as it limits the number of 
sequences (~1012) that can be analyzed. Sample overloading can cause serious loss of resolution 
and result in poor separation of bound and unbound sequences. Secondly, the separation is 
defined by the migration time and thus the collection is made along the separation direction, 
which requires the determination of the fraction collection window while performing the 
separation. Accurate collection time window is important in order not to lose resolution. Dilution 
factor is also an important factor to be considered. In CE-SELEX, the binding complex is 
typically electrophoretically migrated into the collection vial that is also used as buffer reservoir 
for electrophoresis. Considering the small loading capacity and the minimal amount of buffer 
required for electrophoresis, the dilution of the binding sequences after separation is fairly high 
(~104). Therefore, small amount of contaminated sequences can contribute largely to the final 
composition of collected pools, causing deviation from the right track during selection. High 
voltage in CE separation for improving column efficiency and resolution can also be problematic 
as it might disrupt the binding and cause serious complex dissociation in cases involving weak 
binding. 
Similar to CE separation, micro-free flow electrophoresis (µFFE) is also a free solution 
based electrophoresis separation technique. Therefore, it possesses the advantages of CE-SELEX 
such as the high separation resolution and the minimal non-specific interaction. In addition, it 
overcomes many challenges that CE-SELEX encounters. µFFE separates continuous flowing 
sample stream laterally by applying electric field perpendicular to the flow direction of the 
sample stream. The sample introduce and separation are performed along two different 
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dimensions, which allows continuous separation to be carried out and thus greatly expands the 
sample size or the sequence library size that can be analyzed. Bound and unbound fractions are 
collected perpendicular to the deflection direction, allowing the collection window determined 
within predefined area. Since the sample stream is introduced at the center, the bound fraction can 
be collected at either end of the separation chamber. This minimizes the contamination introduced 
in cases where bound sequences are eluted later than free unbound sequences. µFFE-SELEX has 
recently been performed successfully and demonstrated to be a more robust technique than CE-
SELEX 105. We expect more applications of aptamer selection on various targets coming forward. 
Owing to its continuous property, µFFE-SELEX holds great promise in automated SELEX 
platforms. 
 
6.2.2 Aptamers Targeting Endocytosis 
It is straightforward to target the membrane surface receptors involved in the receptor-
mediated endocytosis (RME) for transporting therapeutics into cells. The large extracellular 
domains of the receptors provide perfect binding sites for aptamers to bind and transport. 
Aptamers binding the transmembrane receptor TfR have been selected using CE-SELEX. 
However, the transport potential across plasma membrane of these aptamers remains unclear. 
Future experiments will be focused on whether the aptamers can be endocytosed or they just stay 
bound on the cell membranes. The transportation of the aptamers into the cells can be monitored 
with a confocal fluorescence microscope using dye-labeled aptamers. 
Effective treatment for intracellular targets requires not only the uptake of the 
therapeutics, but also the correct delivery to the destinations where the targets are located. 
Following the ligand binding TfR, the complex is then packaged with the help of adaptor proteins 
into clathrin coated vesicles (CCV), matured to acidified endosomes and then fused with 
lysosomes for digestion and degradation. However, this is not ideal since cargoes are expected to 
enter desired subcellular organelles or be released before fusion with lysosomes. In order to avoid 
lysosomal degradation, other membrane receptors or endocytosis mechanisms should be targeted 
and used for aptamer selection. 
One limitation of the above mentioned clathrin-mediated endocytosis (CME) is the 
inevitable trafficking through acidified endosome to eventually degradative lysosome 228. 
Fortunately alternative endocytosis pathways exist. A clathrin-independent pathway that is named 
caveolin-mediated endocytosis (CvME) involves caveolin internalizing proteins that interact with 
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glycosphingolipid (GSL) in the lipid raft as caveosome and transporting to endoplasmic reticulum 
and then nucleus 229. The protein caveolin does not contain any extracellular portions itself but the 
GSL with exposed carbohydrate groups can be targeted as binding sites for aptamers. Similarly, 
glycosyl phosphatidylinositol (GPI) linked proteins (e.g. folate receptor) can take a clathrin-
independent and caveolin-independent pathway that directs the cargoes to Golgi apparatus 230. 
These alternative endocytosis pathways can also be targeted, which will greatly increase the 
chance of success in finding appropriate targets or aptamers and a variety of organelles can be 
targeted using different receptors and pathways. 
 
6.2.3 Collection and Selection of Catalytic Nucleic Acids 
The microwell array device can only be used for detection purpose. In order to eventually 
identify the catalytic sequences, these sequences need to be collected, amplified and selected 
iteratively to evolve a high abundant pool just like SELEX for aptamers. However, the attempt to 
recover the content of the microwells using micromanipulation is challenging since a large 
portion of the solution transfers to the sealing glass after the PDMS slab is peeled off the glass. 
Water-in-oil emulsion droplets represent better compartments for the purpose of collection and 
recovery of catalytic sequences than the microwells with physical barriers. Various types of 
techniques have been used in microfluidics for droplet sorting and later the collection of droplets 
with desired properties, such as electric force 174, 205, 231, 232, magnetic force 233, hydrodynamic 
force 234, 235, acoustic wave 236 and optical trap 237. 
Droplets containing enzyme molecules have been extensively studied and individual 
droplets have been sorted according to their fluorescence generated by the enzymatic activities. 
Resembling the enzyme molecules, sorting and collection of droplets containing catalytic nucleic 
acids can fit perfectly into the same techniques. A directly accessible planar droplet array on a 
solid surface was invented by Noji group 171. Droplets were discriminated from each other based 
on their fluorescence intensity and further collection was achieved by using a pressure-controlled 
micropipette. Another potential technique is the fluorescence-activated droplet sorting (FADS) 174. 
Water-in-oil droplets were generated by microfluidic flow-focusing of an aqueous stream with 
twin streams of oil phase. The droplets were then incubated in a reservoir for extended period and 
sorted at an asymmetric Y-shaped junction by dielectrophoresis according to fluorescence 
generated by enclosed cells expressing β-galactosidase.  The whole process including incubation, 
detection, sorting and collection can be performed within one integrated piece of PDMS device, 
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and holds promise for automation. However, in this type of techniques, one problem that needs to 
be taken into account is the potential leak of generated fluorescent molecules into the oil phase 
causing cross-talking between droplets, especially when the incubation period is long 171. 
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